BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 924056 COCCn1c(CN2CCN(CC2)c2cccc3O[C@H](Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(=O)OC |r| InChI=1S/C30H30ClFN4O5/c1-38-15-14-36-25-16-19(29(37)39-2)6-9-23(25)33-27(36)18-34-10-12-35(13-11-34)24-4-3-5-26-28(24)41-30(40-26)21-8-7-20(31)17-22(21)32/h3-9,16-17,30H,10-15,18H2,1-2H3 WFMGZVFZKWRRJU-UHFFFAOYSA-N 450624 US10676465, Example 1::2-({4-[2-(4-Chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperazin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, ENT-X1, Trifluoroacetate Salt (1) [from C39]; and 2-({4-[2-(4-Chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperazin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, ENT-X2, Trifluoroacetate Salt (2) [from C40] Glucagon-like peptide 1 receptor Homo sapiens 880 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450624&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818459 440826590 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924057 COCCn1c(CN2CCN(CC2)c2cccc3O[C@H](Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(=O)OC |r| InChI=1S/C30H30ClFN4O5/c1-38-15-14-36-25-16-19(29(37)39-2)6-9-23(25)33-27(36)18-34-10-12-35(13-11-34)24-4-3-5-26-28(24)41-30(40-26)21-8-7-20(31)17-22(21)32/h3-9,16-17,30H,10-15,18H2,1-2H3 WFMGZVFZKWRRJU-UHFFFAOYSA-N 450624 US10676465, Example 1::2-({4-[2-(4-Chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperazin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, ENT-X1, Trifluoroacetate Salt (1) [from C39]; and 2-({4-[2-(4-Chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperazin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, ENT-X2, Trifluoroacetate Salt (2) [from C40] Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450624&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818459 440826590 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924058 COCCn1c(CN2CCN(CC2)c2cccc3O[C@@H](Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(=O)OC |r| InChI=1S/C30H30ClFN4O5/c1-38-15-14-36-25-16-19(29(37)39-2)6-9-23(25)33-27(36)18-34-10-12-35(13-11-34)24-4-3-5-26-28(24)41-30(40-26)21-8-7-20(31)17-22(21)32/h3-9,16-17,30H,10-15,18H2,1-2H3 WFMGZVFZKWRRJU-UHFFFAOYSA-N 450625 US10676465, Example 2* Glucagon-like peptide 1 receptor Homo sapiens 6.60 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450625&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818460 440826591 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924059 COCCn1c(CN2CCN(CC2)c2cccc3O[C@@H](Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(=O)OC |r| InChI=1S/C30H30ClFN4O5/c1-38-15-14-36-25-16-19(29(37)39-2)6-9-23(25)33-27(36)18-34-10-12-35(13-11-34)24-4-3-5-26-28(24)41-30(40-26)21-8-7-20(31)17-22(21)32/h3-9,16-17,30H,10-15,18H2,1-2H3 WFMGZVFZKWRRJU-UHFFFAOYSA-N 450625 US10676465, Example 2* Glucagon-like peptide 1 receptor Homo sapiens 260 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450625&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818460 440826591 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924060 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ncc(cc12)C(O)=O InChI=1S/C30H30ClFN4O5/c1-30(22-7-6-20(31)15-23(22)32)40-25-5-3-4-21(27(25)41-30)18-8-10-35(11-9-18)17-26-34-28-24(36(26)12-13-39-2)14-19(16-33-28)29(37)38/h3-7,14-16,18H,8-13,17H2,1-2H3,(H,37,38) QOVNYZMDAGSOBR-UHFFFAOYSA-N 450626 US10676465, Example 3::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyridine-6-Carboxylic Acid, Trifluoroacetate Salt Glucagon-like peptide 1 receptor Homo sapiens 1.30 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450626&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609004 440826592 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924061 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ncc(cc12)C(O)=O InChI=1S/C30H30ClFN4O5/c1-30(22-7-6-20(31)15-23(22)32)40-25-5-3-4-21(27(25)41-30)18-8-10-35(11-9-18)17-26-34-28-24(36(26)12-13-39-2)14-19(16-33-28)29(37)38/h3-7,14-16,18H,8-13,17H2,1-2H3,(H,37,38) QOVNYZMDAGSOBR-UHFFFAOYSA-N 450626 US10676465, Example 3::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyridine-6-Carboxylic Acid, Trifluoroacetate Salt Glucagon-like peptide 1 receptor Homo sapiens 45.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450626&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609004 440826592 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924062 [O-]C(=O)c1ccc2nc(CN3CCC(CC3)c3cccc4O[C@H](Oc34)c3ccc(Cl)cc3F)n(C[C@@H]3CCO3)c2c1 |r| InChI=1S/C31H29ClFN3O5/c32-20-5-6-23(24(33)15-20)31-40-27-3-1-2-22(29(27)41-31)18-8-11-35(12-9-18)17-28-34-25-7-4-19(30(37)38)14-26(25)36(28)16-21-10-13-39-21/h1-7,14-15,18,21,31H,8-13,16-17H2,(H,37,38)/p-1 VNPABHMVWOQTPL-UHFFFAOYSA-M 450627 US10676465, Example 4::Ammonium 2-({4-[(2R)-2-(4-chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (4) and Ammonium 2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (5) Glucagon-like peptide 1 receptor Homo sapiens 1600 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450627&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295680 440826593 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924063 [O-]C(=O)c1ccc2nc(CN3CCC(CC3)c3cccc4O[C@H](Oc34)c3ccc(Cl)cc3F)n(C[C@@H]3CCO3)c2c1 |r| InChI=1S/C31H29ClFN3O5/c32-20-5-6-23(24(33)15-20)31-40-27-3-1-2-22(29(27)41-31)18-8-11-35(12-9-18)17-28-34-25-7-4-19(30(37)38)14-26(25)36(28)16-21-10-13-39-21/h1-7,14-15,18,21,31H,8-13,16-17H2,(H,37,38)/p-1 VNPABHMVWOQTPL-UHFFFAOYSA-M 450627 US10676465, Example 4::Ammonium 2-({4-[(2R)-2-(4-chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (4) and Ammonium 2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (5) Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450627&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295680 440826593 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924064 [O-]C(=O)c1ccc2nc(CN3CCC(CC3)c3cccc4O[C@@H](Oc34)c3ccc(Cl)cc3F)n(C[C@@H]3CCO3)c2c1 |r| InChI=1S/C31H29ClFN3O5/c32-20-5-6-23(24(33)15-20)31-40-27-3-1-2-22(29(27)41-31)18-8-11-35(12-9-18)17-28-34-25-7-4-19(30(37)38)14-26(25)36(28)16-21-10-13-39-21/h1-7,14-15,18,21,31H,8-13,16-17H2,(H,37,38)/p-1 VNPABHMVWOQTPL-UHFFFAOYSA-M 450628 US10676465, Example 5** Glucagon-like peptide 1 receptor Homo sapiens 1.30 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450628&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 152162901 440826594 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924065 [O-]C(=O)c1ccc2nc(CN3CCC(CC3)c3cccc4O[C@@H](Oc34)c3ccc(Cl)cc3F)n(C[C@@H]3CCO3)c2c1 |r| InChI=1S/C31H29ClFN3O5/c32-20-5-6-23(24(33)15-20)31-40-27-3-1-2-22(29(27)41-31)18-8-11-35(12-9-18)17-28-34-25-7-4-19(30(37)38)14-26(25)36(28)16-21-10-13-39-21/h1-7,14-15,18,21,31H,8-13,16-17H2,(H,37,38)/p-1 VNPABHMVWOQTPL-UHFFFAOYSA-M 450628 US10676465, Example 5** Glucagon-like peptide 1 receptor Homo sapiens 23.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450628&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 152162901 440826594 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924066 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C([O-])=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)18-29-35-26-8-5-20(31(38)39)15-27(26)37(29)17-22-11-14-40-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39)/p-1 PVJIBTUECCAKKZ-UHFFFAOYSA-M 450629 US10676465, Example 6::Ammonium 2-({4-[(2R)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (6) and Ammonium 2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (7) Glucagon-like peptide 1 receptor Homo sapiens 140 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450629&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 148979054 440826595 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924067 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C([O-])=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)18-29-35-26-8-5-20(31(38)39)15-27(26)37(29)17-22-11-14-40-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39)/p-1 PVJIBTUECCAKKZ-UHFFFAOYSA-M 450629 US10676465, Example 6::Ammonium 2-({4-[(2R)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (6) and Ammonium 2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylate (7) Glucagon-like peptide 1 receptor Homo sapiens 2400 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450629&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 148979054 440826595 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924068 C[C@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C([O-])=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)18-29-35-26-8-5-20(31(38)39)15-27(26)37(29)17-22-11-14-40-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39)/p-1 PVJIBTUECCAKKZ-UHFFFAOYSA-M 450630 US10676465, Example 7** Glucagon-like peptide 1 receptor Homo sapiens 0.260 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450630&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153298010 440826596 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924069 C[C@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C([O-])=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)18-29-35-26-8-5-20(31(38)39)15-27(26)37(29)17-22-11-14-40-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39)/p-1 PVJIBTUECCAKKZ-UHFFFAOYSA-M 450630 US10676465, Example 7** Glucagon-like peptide 1 receptor Homo sapiens 3.10 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450630&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153298010 440826596 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924070 C[C@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(cc1F)C#N |r| InChI=1S/C33H31FN4O5/c1-33(25-7-5-20(17-35)15-26(25)34)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)19-30-36-27-8-6-22(32(39)40)16-28(27)38(30)18-23-11-14-41-23/h2-8,15-16,21,23H,9-14,18-19H2,1H3,(H,39,40) DNHKHVBMYRQKSG-UHFFFAOYSA-N 450631 US10676465, Example 8*** Glucagon-like peptide 1 receptor Homo sapiens 0.300 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450631&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609117 440826597 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924071 C[C@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(cc1F)C#N |r| InChI=1S/C33H31FN4O5/c1-33(25-7-5-20(17-35)15-26(25)34)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)19-30-36-27-8-6-22(32(39)40)16-28(27)38(30)18-23-11-14-41-23/h2-8,15-16,21,23H,9-14,18-19H2,1H3,(H,39,40) DNHKHVBMYRQKSG-UHFFFAOYSA-N 450631 US10676465, Example 8*** Glucagon-like peptide 1 receptor Homo sapiens 3.60 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450631&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609117 440826597 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924072 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(cc1F)C#N |r| InChI=1S/C33H31FN4O5/c1-33(25-7-5-20(17-35)15-26(25)34)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)19-30-36-27-8-6-22(32(39)40)16-28(27)38(30)18-23-11-14-41-23/h2-8,15-16,21,23H,9-14,18-19H2,1H3,(H,39,40) DNHKHVBMYRQKSG-UHFFFAOYSA-N 450632 US10676465, Example 9 Glucagon-like peptide 1 receptor Homo sapiens 73.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450632&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609041 440826598 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924073 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(cc1F)C#N |r| InChI=1S/C33H31FN4O5/c1-33(25-7-5-20(17-35)15-26(25)34)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)19-30-36-27-8-6-22(32(39)40)16-28(27)38(30)18-23-11-14-41-23/h2-8,15-16,21,23H,9-14,18-19H2,1H3,(H,39,40) DNHKHVBMYRQKSG-UHFFFAOYSA-N 450632 US10676465, Example 9 Glucagon-like peptide 1 receptor Homo sapiens 1600 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450632&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609041 440826598 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924074 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cn1 |r| InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38) SVPYZAJTWFQTSM-UHFFFAOYSA-N 450633 US10676465, Example 10 Glucagon-like peptide 1 receptor Homo sapiens 0.960 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450633 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450633&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609022 440826599 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924075 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cn1 |r| InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38) SVPYZAJTWFQTSM-UHFFFAOYSA-N 450633 US10676465, Example 10 Glucagon-like peptide 1 receptor Homo sapiens 17.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450633 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450633&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609022 440826599 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924076 COCCn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2cccnc2)nc2ccc(cc12)C(O)=O |r| InChI=1S/C30H32N4O5/c1-30(22-5-4-12-31-18-22)38-26-7-3-6-23(28(26)39-30)20-10-13-33(14-11-20)19-27-32-24-9-8-21(29(35)36)17-25(24)34(27)15-16-37-2/h3-9,12,17-18,20H,10-11,13-16,19H2,1-2H3,(H,35,36) MWEOWNXDSFVUKW-UHFFFAOYSA-N 450634 US10676465, Example 11::1-(2-Methoxyethyl)-2-({4-[2-methyl-2-(pyridin-3-yl)-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1H-benzimidazole-6-carboxylic Acid, Formate Salt Glucagon-like peptide 1 receptor Homo sapiens 290 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450634&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818461 440826600 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924077 CN(C)CCn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C32H34ClFN4O4/c1-32(24-9-8-22(33)18-25(24)34)41-28-6-4-5-23(30(28)42-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)16-15-36(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) SLIPCGBKLNRITA-UHFFFAOYSA-N 450635 US10676465, Example 12::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[2-(dimethylamino)ethyl]-1H-benzimidazole-6-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 29.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450635 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450635&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818462 440826601 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924078 CN(C)CCn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C32H34ClFN4O4/c1-32(24-9-8-22(33)18-25(24)34)41-28-6-4-5-23(30(28)42-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)16-15-36(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) SLIPCGBKLNRITA-UHFFFAOYSA-N 450635 US10676465, Example 12::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[2-(dimethylamino)ethyl]-1H-benzimidazole-6-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 690 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450635 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450635&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818462 440826601 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924079 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H28ClFN4O5/c1-32(23-7-6-21(33)16-24(23)34)42-27-4-2-3-22(30(27)43-32)19-9-12-37(13-10-19)17-28-36-25-8-5-20(31(39)40)15-26(25)38(28)18-29-35-11-14-41-29/h2-8,11,14-16,19H,9-10,12-13,17-18H2,1H3,(H,39,40) ACCVHTRNZBMGKN-UHFFFAOYSA-N 450636 US10676465, Example 13::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 4.50 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450636&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818463 440826602 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924080 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H28ClFN4O5/c1-32(23-7-6-21(33)16-24(23)34)42-27-4-2-3-22(30(27)43-32)19-9-12-37(13-10-19)17-28-36-25-8-5-20(31(39)40)15-26(25)38(28)18-29-35-11-14-41-29/h2-8,11,14-16,19H,9-10,12-13,17-18H2,1H3,(H,39,40) ACCVHTRNZBMGKN-UHFFFAOYSA-N 450636 US10676465, Example 13::2-({4-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 38.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450636&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818463 440826602 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924081 Cn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C29H27ClFN3O4/c1-29(21-8-7-19(30)15-22(21)31)37-25-5-3-4-20(27(25)38-29)17-10-12-34(13-11-17)16-26-32-23-9-6-18(28(35)36)14-24(23)33(26)2/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,35,36) KKVUJLLCGFSOMG-UHFFFAOYSA-N 450637 US10676465, Example 14::2-({4-[(2S)-2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-methyl-1H-benzimidazole-6-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 7.00 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450637&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608995 440826603 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924082 Cn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C29H27ClFN3O4/c1-29(21-8-7-19(30)15-22(21)31)37-25-5-3-4-20(27(25)38-29)17-10-12-34(13-11-17)16-26-32-23-9-6-18(28(35)36)14-24(23)33(26)2/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,35,36) KKVUJLLCGFSOMG-UHFFFAOYSA-N 450637 US10676465, Example 14::2-({4-[(2S)-2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-methyl-1H-benzimidazole-6-carboxylic Acid Glucagon-like peptide 1 receptor Homo sapiens 79.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450637&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608995 440826603 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924083 COCCn1c(nc2ccc(cc12)C(=O)OC)[C@@H]1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-32(22-9-8-21(34)18-24(22)35)42-28-6-4-5-26(29(28)43-32)37-13-11-33(12-14-37)19-23(33)30-36-25-10-7-20(31(39)41-3)17-27(25)38(30)15-16-40-2/h4-10,17-18,23H,11-16,19H2,1-3H3 GAZVOJHPIOZHSZ-UHFFFAOYSA-N 450638 US10676465, Example 15::2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X1, Trifluoroacetate Salt (15) [from P18 Via C71]; and 2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X2, Trifluoroacetate Salt (16) [from P18 Via C72] Glucagon-like peptide 1 receptor Homo sapiens >18000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450638&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146651762 440826604 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924084 COCCn1c(nc2ccc(cc12)C(=O)OC)[C@@H]1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-32(22-9-8-21(34)18-24(22)35)42-28-6-4-5-26(29(28)43-32)37-13-11-33(12-14-37)19-23(33)30-36-25-10-7-20(31(39)41-3)17-27(25)38(30)15-16-40-2/h4-10,17-18,23H,11-16,19H2,1-3H3 GAZVOJHPIOZHSZ-UHFFFAOYSA-N 450638 US10676465, Example 15::2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X1, Trifluoroacetate Salt (15) [from P18 Via C71]; and 2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X2, Trifluoroacetate Salt (16) [from P18 Via C72] Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450638&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146651762 440826604 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924085 COCCn1c(nc2ccc(cc12)C(=O)OC)[C@H]1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-32(22-9-8-21(34)18-24(22)35)42-28-6-4-5-26(29(28)43-32)37-13-11-33(12-14-37)19-23(33)30-36-25-10-7-20(31(39)41-3)17-27(25)38(30)15-16-40-2/h4-10,17-18,23H,11-16,19H2,1-3H3 GAZVOJHPIOZHSZ-UHFFFAOYSA-N 450639 US10676465, Example 16::2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X1, Trifluoroacetate Salt (15) [from P18 Via C71]; and 2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X2, Trifluoroacetate Salt (16) [from P18 Via C72] Glucagon-like peptide 1 receptor Homo sapiens 7.70 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450639&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818464 440826605 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924086 COCCn1c(nc2ccc(cc12)C(=O)OC)[C@H]1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-32(22-9-8-21(34)18-24(22)35)42-28-6-4-5-26(29(28)43-32)37-13-11-33(12-14-37)19-23(33)30-36-25-10-7-20(31(39)41-3)17-27(25)38(30)15-16-40-2/h4-10,17-18,23H,11-16,19H2,1-3H3 GAZVOJHPIOZHSZ-UHFFFAOYSA-N 450639 US10676465, Example 16::2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X1, Trifluoroacetate Salt (15) [from P18 Via C71]; and 2-{6-[2-(4-Chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-6-azaspiro[2.5]oct-1-yl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic Acid, DIAST-X2, Trifluoroacetate Salt (16) [from P18 Via C72] Glucagon-like peptide 1 receptor Homo sapiens 120 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450639&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818464 440826605 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924087 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C34H33ClFN5O4/c1-3-40-20-37-17-24(40)18-41-29-15-22(33(42)43)7-10-28(29)38-31(41)19-39-13-11-21(12-14-39)25-5-4-6-30-32(25)45-34(2,44-30)26-9-8-23(35)16-27(26)36/h4-10,15-17,20-21H,3,11-14,18-19H2,1-2H3,(H,42,43) WEKDLJZWMRXENF-UHFFFAOYSA-N 450640 US10676465, Example 17::Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-1 (17) and Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-2 (18) Glucagon-like peptide 1 receptor Homo sapiens 0.079 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450640&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609000 440826606 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924088 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc3O[C@@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C34H33ClFN5O4/c1-3-40-20-37-17-24(40)18-41-29-15-22(33(42)43)7-10-28(29)38-31(41)19-39-13-11-21(12-14-39)25-5-4-6-30-32(25)45-34(2,44-30)26-9-8-23(35)16-27(26)36/h4-10,15-17,20-21H,3,11-14,18-19H2,1-2H3,(H,42,43) WEKDLJZWMRXENF-UHFFFAOYSA-N 450640 US10676465, Example 17::Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-1 (17) and Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-2 (18) Glucagon-like peptide 1 receptor Homo sapiens 1.10 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450640&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609000 440826606 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924089 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc3O[C@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C34H33ClFN5O4/c1-3-40-20-37-17-24(40)18-41-29-15-22(33(42)43)7-10-28(29)38-31(41)19-39-13-11-21(12-14-39)25-5-4-6-30-32(25)45-34(2,44-30)26-9-8-23(35)16-27(26)36/h4-10,15-17,20-21H,3,11-14,18-19H2,1-2H3,(H,42,43) WEKDLJZWMRXENF-UHFFFAOYSA-N 450641 US10676465, Example 18::Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-1 (17) and Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-2 (18) Glucagon-like peptide 1 receptor Homo sapiens 210 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450641&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608998 440826607 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924090 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc3O[C@](C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O |r| InChI=1S/C34H33ClFN5O4/c1-3-40-20-37-17-24(40)18-41-29-15-22(33(42)43)7-10-28(29)38-31(41)19-39-13-11-21(12-14-39)25-5-4-6-30-32(25)45-34(2,44-30)26-9-8-23(35)16-27(26)36/h4-10,15-17,20-21H,3,11-14,18-19H2,1-2H3,(H,42,43) WEKDLJZWMRXENF-UHFFFAOYSA-N 450641 US10676465, Example 18::Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-1 (17) and Ammonium 2-({4-[2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl}methyl)-1-[(I-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylate, ENT-2 (18) Glucagon-like peptide 1 receptor Homo sapiens 1000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450641&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608998 440826607 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924091 COCCn1c(CN2CCN(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H30ClFN4O5/c1-30(21-8-7-20(31)17-22(21)32)40-26-5-3-4-24(28(26)41-30)35-12-10-34(11-13-35)18-27-33-23-9-6-19(29(37)38)16-25(23)36(27)14-15-39-2/h3-9,16-17H,10-15,18H2,1-2H3,(H,37,38) WQQFSTDTJAHMTN-UHFFFAOYSA-N 450642 US10676465, Example 19::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperazin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 1.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450642&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609162 440826608 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924092 COCCn1c(CN2CCN(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H30ClFN4O5/c1-30(21-8-7-20(31)17-22(21)32)40-26-5-3-4-24(28(26)41-30)35-12-10-34(11-13-35)18-27-33-23-9-6-19(29(37)38)16-25(23)36(27)14-15-39-2/h3-9,16-17H,10-15,18H2,1-2H3,(H,37,38) WQQFSTDTJAHMTN-UHFFFAOYSA-N 450642 US10676465, Example 19::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperazin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 25.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450642&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609162 440826608 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924093 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN3O5/c1-38-14-13-35-25-15-19(29(36)37)5-8-24(25)33-27(35)17-34-11-9-18(10-12-34)21-3-2-4-26-28(21)40-30(39-26)22-7-6-20(31)16-23(22)32/h2-8,15-16,18,30H,9-14,17H2,1H3,(H,36,37) BDPYFLYJAWCBSZ-UHFFFAOYSA-N 450643 US10676465, Example 20::US10676465, Example 21::2-({4-[2-(4-chloro-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, ENT-X2, trifluoroacetate salt, [from C77; footnote 1 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 17.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450643&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609116 440826609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924094 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN3O5/c1-38-14-13-35-25-15-19(29(36)37)5-8-24(25)33-27(35)17-34-11-9-18(10-12-34)21-3-2-4-26-28(21)40-30(39-26)22-7-6-20(31)16-23(22)32/h2-8,15-16,18,30H,9-14,17H2,1H3,(H,36,37) BDPYFLYJAWCBSZ-UHFFFAOYSA-N 450643 US10676465, Example 20::US10676465, Example 21::2-({4-[2-(4-chloro-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, ENT-X2, trifluoroacetate salt, [from C77; footnote 1 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 270 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450643&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609116 440826609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924095 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN3O5/c1-38-14-13-35-25-15-19(29(36)37)5-8-24(25)33-27(35)17-34-11-9-18(10-12-34)21-3-2-4-26-28(21)40-30(39-26)22-7-6-20(31)16-23(22)32/h2-8,15-16,18,30H,9-14,17H2,1H3,(H,36,37) BDPYFLYJAWCBSZ-UHFFFAOYSA-N 450643 US10676465, Example 20::US10676465, Example 21::2-({4-[2-(4-chloro-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, ENT-X2, trifluoroacetate salt, [from C77; footnote 1 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450643&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609116 440826609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924096 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN3O5/c1-38-14-13-35-25-15-19(29(36)37)5-8-24(25)33-27(35)17-34-11-9-18(10-12-34)21-3-2-4-26-28(21)40-30(39-26)22-7-6-20(31)16-23(22)32/h2-8,15-16,18,30H,9-14,17H2,1H3,(H,36,37) BDPYFLYJAWCBSZ-UHFFFAOYSA-N 450643 US10676465, Example 20::US10676465, Example 21::2-({4-[2-(4-chloro-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, ENT-X2, trifluoroacetate salt, [from C77; footnote 1 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450643&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609116 440826609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924097 COCCn1c(CN2CCN(CC2)c2cccc3OC(Oc23)c2ccccc2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30N4O5/c1-36-17-16-33-24-18-21(28(34)35)10-11-22(24)30-26(33)19-31-12-14-32(15-13-31)23-8-5-9-25-27(23)38-29(37-25)20-6-3-2-4-7-20/h2-11,18,29H,12-17,19H2,1H3,(H,34,35) SVBZCXLXGVIDCB-UHFFFAOYSA-N 450645 US10676465, Example 22::1-(2-methoxyethyl)-2-{[4-(2-phenyl-1,3- benzodioxol-4-yl)piperazin-1-yl]methyl}- 1H-benzimidazole-6-carboxylic acid, ENT-X1, trifluoroacetate salt, [from P5]::US10676465, Example 23 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450645 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450645&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609105 440826610 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924098 COCCn1c(CN2CCN(CC2)c2cccc3OC(Oc23)c2ccccc2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30N4O5/c1-36-17-16-33-24-18-21(28(34)35)10-11-22(24)30-26(33)19-31-12-14-32(15-13-31)23-8-5-9-25-27(23)38-29(37-25)20-6-3-2-4-7-20/h2-11,18,29H,12-17,19H2,1H3,(H,34,35) SVBZCXLXGVIDCB-UHFFFAOYSA-N 450645 US10676465, Example 22::1-(2-methoxyethyl)-2-{[4-(2-phenyl-1,3- benzodioxol-4-yl)piperazin-1-yl]methyl}- 1H-benzimidazole-6-carboxylic acid, ENT-X1, trifluoroacetate salt, [from P5]::US10676465, Example 23 Glucagon-like peptide 1 receptor Homo sapiens 680 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450645 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450645&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609105 440826610 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924099 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN3O5/c1-31(23-8-7-21(32)17-24(23)33)40-27-5-3-4-22(29(27)41-31)19-10-12-35(13-11-19)18-28-34-25-9-6-20(30(37)38)16-26(25)36(28)14-15-39-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,37,38) IPKDCFVAZAKGAQ-UHFFFAOYSA-N 450647 US10676465, Example 24::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 1.40 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450647 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450647&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609070 440826611 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924100 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN3O5/c1-31(23-8-7-21(32)17-24(23)33)40-27-5-3-4-22(29(27)41-31)19-10-12-35(13-11-19)18-28-34-25-9-6-20(30(37)38)16-26(25)36(28)14-15-39-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,37,38) IPKDCFVAZAKGAQ-UHFFFAOYSA-N 450647 US10676465, Example 24::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 49.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450647 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450647&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609070 440826611 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924101 COCCn1c(nc2ccc(cc12)C(O)=O)C1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-31(21-8-7-20(33)17-23(21)34)41-27-5-3-4-25(28(27)42-31)36-12-10-32(11-13-36)18-22(32)29-35-24-9-6-19(30(38)39)16-26(24)37(29)14-15-40-2/h3-9,16-17,22H,10-15,18H2,1-2H3,(H,38,39) XRSMEBYLZFDHKI-UHFFFAOYSA-N 450648 US10676465, Example 25::2-{6-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]-6- azaspiro[2.5]oct-1-yl}-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylic acid, DIAST-Z2, trifluoroacetate salt, [from P17 via C79; footnote 2 in Table 2]::US10676465, Example 26 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450648&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609017 440826612 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924102 COCCn1c(nc2ccc(cc12)C(O)=O)C1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-31(21-8-7-20(33)17-23(21)34)41-27-5-3-4-25(28(27)42-31)36-12-10-32(11-13-36)18-22(32)29-35-24-9-6-19(30(38)39)16-26(24)37(29)14-15-40-2/h3-9,16-17,22H,10-15,18H2,1-2H3,(H,38,39) XRSMEBYLZFDHKI-UHFFFAOYSA-N 450648 US10676465, Example 25::2-{6-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]-6- azaspiro[2.5]oct-1-yl}-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylic acid, DIAST-Z2, trifluoroacetate salt, [from P17 via C79; footnote 2 in Table 2]::US10676465, Example 26 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450648&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609017 440826612 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924103 COCCn1c(nc2ccc(cc12)C(O)=O)C1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-31(21-8-7-20(33)17-23(21)34)41-27-5-3-4-25(28(27)42-31)36-12-10-32(11-13-36)18-22(32)29-35-24-9-6-19(30(38)39)16-26(24)37(29)14-15-40-2/h3-9,16-17,22H,10-15,18H2,1-2H3,(H,38,39) XRSMEBYLZFDHKI-UHFFFAOYSA-N 450648 US10676465, Example 25::2-{6-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]-6- azaspiro[2.5]oct-1-yl}-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylic acid, DIAST-Z2, trifluoroacetate salt, [from P17 via C79; footnote 2 in Table 2]::US10676465, Example 26 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450648&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609017 440826612 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924104 COCCn1c(nc2ccc(cc12)C(O)=O)C1CC11CCN(CC1)c1cccc2OC(C)(Oc12)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-31(21-8-7-20(33)17-23(21)34)41-27-5-3-4-25(28(27)42-31)36-12-10-32(11-13-36)18-22(32)29-35-24-9-6-19(30(38)39)16-26(24)37(29)14-15-40-2/h3-9,16-17,22H,10-15,18H2,1-2H3,(H,38,39) XRSMEBYLZFDHKI-UHFFFAOYSA-N 450648 US10676465, Example 25::2-{6-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]-6- azaspiro[2.5]oct-1-yl}-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylic acid, DIAST-Z2, trifluoroacetate salt, [from P17 via C79; footnote 2 in Table 2]::US10676465, Example 26 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450648&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609017 440826612 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924105 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(cc2F)C#N)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN4O5/c1-39-14-13-36-26-16-21(30(37)38)6-8-25(26)34-28(36)18-35-11-9-20(10-12-35)22-3-2-4-27-29(22)41-31(40-27)23-7-5-19(17-33)15-24(23)32/h2-8,15-16,20,31H,9-14,18H2,1H3,(H,37,38) JXVJBNDHBBFJAK-UHFFFAOYSA-N 450650 US10676465, Example 27::2-({4-[2-(4-cyano-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 61.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450650 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450650&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609108 440826613 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924106 COCCn1c(CN2CCC(CC2)c2cccc3OC(Oc23)c2ccc(cc2F)C#N)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN4O5/c1-39-14-13-36-26-16-21(30(37)38)6-8-25(26)34-28(36)18-35-11-9-20(10-12-35)22-3-2-4-27-29(22)41-31(40-27)23-7-5-19(17-33)15-24(23)32/h2-8,15-16,20,31H,9-14,18H2,1H3,(H,37,38) JXVJBNDHBBFJAK-UHFFFAOYSA-N 450650 US10676465, Example 27::2-({4-[2-(4-cyano-2-fluorophenyl)-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 1000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450650 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450650&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609108 440826613 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924107 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(c2)C(F)(F)F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32F3N3O5/c1-31(22-5-3-6-23(18-22)32(33,34)35)42-27-8-4-7-24(29(27)43-31)20-11-13-37(14-12-20)19-28-36-25-10-9-21(30(39)40)17-26(25)38(28)15-16-41-2/h3-10,17-18,20H,11-16,19H2,1-2H3,(H,39,40) RVQKWKPQZVKUAP-UHFFFAOYSA-N 450651 US10676465, Example 28::1-(2-methoxyethyl)-2-[(4-{2-methyl-2-[3- (trifluoromethyl)phenyl]-1,3-benzodioxol- 4-yl}piperidin-1-yl)methyl]-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 480 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450651&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609135 440826614 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924108 CCc1ccc(cc1)C1(C)Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCOC)C(O)=O)CC3)c2O1 InChI=1S/C33H37N3O5/c1-4-22-8-11-25(12-9-22)33(2)40-29-7-5-6-26(31(29)41-33)23-14-16-35(17-15-23)21-30-34-27-13-10-24(32(37)38)20-28(27)36(30)18-19-39-3/h5-13,20,23H,4,14-19,21H2,1-3H3,(H,37,38) XOUQYDOEPWOCKV-UHFFFAOYSA-N 450652 US10676465, Example 29::2-({4-[2-(4-ethylphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 5.30 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450652 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450652&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609132 440826615 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924109 CCc1ccc(cc1)C1(C)Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCOC)C(O)=O)CC3)c2O1 InChI=1S/C33H37N3O5/c1-4-22-8-11-25(12-9-22)33(2)40-29-7-5-6-26(31(29)41-33)23-14-16-35(17-15-23)21-30-34-27-13-10-24(32(37)38)20-28(27)36(30)18-19-39-3/h5-13,20,23H,4,14-19,21H2,1-3H3,(H,37,38) XOUQYDOEPWOCKV-UHFFFAOYSA-N 450652 US10676465, Example 29::2-({4-[2-(4-ethylphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 150 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450652 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450652&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609132 440826615 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924110 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)c(F)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O6/c1-32(22-8-10-27(40-3)24(33)18-22)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-25-9-7-21(31(37)38)17-26(25)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) BMAZFYLSSOXIHF-UHFFFAOYSA-N 450653 US10676465, Example 30::2-({4-[2-(3-fluoro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 45.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450653&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609136 440826616 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924111 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)c(F)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O6/c1-32(22-8-10-27(40-3)24(33)18-22)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-25-9-7-21(31(37)38)17-26(25)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) BMAZFYLSSOXIHF-UHFFFAOYSA-N 450653 US10676465, Example 30::2-({4-[2-(3-fluoro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 1100 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450653&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609136 440826616 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924112 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(F)c2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32FN3O5/c1-31(22-5-3-6-23(32)18-22)39-27-8-4-7-24(29(27)40-31)20-11-13-34(14-12-20)19-28-33-25-10-9-21(30(36)37)17-26(25)35(28)15-16-38-2/h3-10,17-18,20H,11-16,19H2,1-2H3,(H,36,37) IYJRSYIJESJPBQ-UHFFFAOYSA-N 450654 US10676465, Example 31::2-({4-[2-(3-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 190 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450654 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450654&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609068 440826617 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924113 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(F)c2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32FN3O5/c1-31(22-5-3-6-23(32)18-22)39-27-8-4-7-24(29(27)40-31)20-11-13-34(14-12-20)19-28-33-25-10-9-21(30(36)37)17-26(25)35(28)15-16-38-2/h3-10,17-18,20H,11-16,19H2,1-2H3,(H,36,37) IYJRSYIJESJPBQ-UHFFFAOYSA-N 450654 US10676465, Example 31::2-({4-[2-(3-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 1900 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450654 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450654&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609068 440826617 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924114 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O6/c1-32(23-8-10-24(39-3)11-9-23)40-28-6-4-5-25(30(28)41-32)21-13-15-34(16-14-21)20-29-33-26-12-7-22(31(36)37)19-27(26)35(29)17-18-38-2/h4-12,19,21H,13-18,20H2,1-3H3,(H,36,37) GGAGXIPWBVPMSC-UHFFFAOYSA-N 450655 US10676465, Example 32::1-(2-methoxyethyl)-2-({4-[2-(4- methoxyphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 18.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450655 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450655&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609043 440826618 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924115 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O6/c1-32(23-8-10-24(39-3)11-9-23)40-28-6-4-5-25(30(28)41-32)21-13-15-34(16-14-21)20-29-33-26-12-7-22(31(36)37)19-27(26)35(29)17-18-38-2/h4-12,19,21H,13-18,20H2,1-3H3,(H,36,37) GGAGXIPWBVPMSC-UHFFFAOYSA-N 450655 US10676465, Example 32::1-(2-methoxyethyl)-2-({4-[2-(4- methoxyphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 450 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450655 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450655&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609043 440826618 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924116 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClN3O5/c1-31(22-7-9-23(32)10-8-22)39-27-5-3-4-24(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-6-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) DBPYPAUEESEXGS-UHFFFAOYSA-N 450656 US10676465, Example 33::2-({4-[2-(4-chlorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 2.60 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450656&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609156 440826619 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924117 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClN3O5/c1-31(22-7-9-23(32)10-8-22)39-27-5-3-4-24(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-6-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) DBPYPAUEESEXGS-UHFFFAOYSA-N 450656 US10676465, Example 33::2-({4-[2-(4-chlorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 100.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450656&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609156 440826619 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924118 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cc2)C#N)nc2ccc(cc12)C(O)=O InChI=1S/C32H32N4O5/c1-32(24-9-6-21(19-33)7-10-24)40-28-5-3-4-25(30(28)41-32)22-12-14-35(15-13-22)20-29-34-26-11-8-23(31(37)38)18-27(26)36(29)16-17-39-2/h3-11,18,22H,12-17,20H2,1-2H3,(H,37,38) BSFLMKRMDUEMTP-UHFFFAOYSA-N 450657 US10676465, Example 34::2-({4-[2-(4-cyanophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 7.80 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450657&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609114 440826620 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924119 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cc2)C#N)nc2ccc(cc12)C(O)=O InChI=1S/C32H32N4O5/c1-32(24-9-6-21(19-33)7-10-24)40-28-5-3-4-25(30(28)41-32)22-12-14-35(15-13-22)20-29-34-26-11-8-23(31(37)38)18-27(26)36(29)16-17-39-2/h3-11,18,22H,12-17,20H2,1-2H3,(H,37,38) BSFLMKRMDUEMTP-UHFFFAOYSA-N 450657 US10676465, Example 34::2-({4-[2-(4-cyanophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 110 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450657&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609114 440826620 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924120 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O6/c1-32(24-9-8-22(40-3)18-25(24)33)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-26-10-7-21(31(37)38)17-27(26)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) GMLFOAOBEKEPIR-UHFFFAOYSA-N 450658 US10676465, Example 35::2-({4-[2-(2-fluoro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 6.60 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450658&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609058 440826621 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924121 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O6/c1-32(24-9-8-22(40-3)18-25(24)33)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-26-10-7-21(31(37)38)17-27(26)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) GMLFOAOBEKEPIR-UHFFFAOYSA-N 450658 US10676465, Example 35::2-({4-[2-(2-fluoro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 170 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450658&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609058 440826621 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924122 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(C)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34N4O5/c1-20-6-4-9-27(32-20)31(2)39-26-8-5-7-23(29(26)40-31)21-12-14-34(15-13-21)19-28-33-24-11-10-22(30(36)37)18-25(24)35(28)16-17-38-3/h4-11,18,21H,12-17,19H2,1-3H3,(H,36,37) PIWLVZDUDUFWMZ-UHFFFAOYSA-N 450659 US10676465, Example 36::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(6- methylpyridin-2-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 760 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450659&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609086 440826622 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924123 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2OC)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O6/c1-32(24-8-4-5-9-27(24)39-3)40-28-10-6-7-23(30(28)41-32)21-13-15-34(16-14-21)20-29-33-25-12-11-22(31(36)37)19-26(25)35(29)17-18-38-2/h4-12,19,21H,13-18,20H2,1-3H3,(H,36,37) PIEGBTLJKHRTEC-UHFFFAOYSA-N 450660 US10676465, Example 37::1-(2-methoxyethyl)-2-({4-[2-(2- methoxyphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 81.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450660&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609161 440826623 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924124 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2OC)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O6/c1-32(24-8-4-5-9-27(24)39-3)40-28-10-6-7-23(30(28)41-32)21-13-15-34(16-14-21)20-29-33-25-12-11-22(31(36)37)19-26(25)35(29)17-18-38-2/h4-12,19,21H,13-18,20H2,1-3H3,(H,36,37) PIEGBTLJKHRTEC-UHFFFAOYSA-N 450660 US10676465, Example 37::1-(2-methoxyethyl)-2-({4-[2-(2- methoxyphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450660&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609161 440826623 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924125 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(F)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32FN3O5/c1-31(22-7-9-23(32)10-8-22)39-27-5-3-4-24(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-6-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) GHSMNLVQGDMWOQ-UHFFFAOYSA-N 450661 US10676465, Example 38::2-({4-[2-(4-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 10.00 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450661&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609056 440826624 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924126 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(F)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32FN3O5/c1-31(22-7-9-23(32)10-8-22)39-27-5-3-4-24(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-6-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) GHSMNLVQGDMWOQ-UHFFFAOYSA-N 450661 US10676465, Example 38::2-({4-[2-(4-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 240 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450661&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609056 440826624 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924127 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(OC)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O6/c1-32(23-6-4-7-24(19-23)39-3)40-28-9-5-8-25(30(28)41-32)21-12-14-34(15-13-21)20-29-33-26-11-10-22(31(36)37)18-27(26)35(29)16-17-38-2/h4-11,18-19,21H,12-17,20H2,1-3H3,(H,36,37) QLQHHNXWWDOLTO-UHFFFAOYSA-N 450662 US10676465, Example 39::1-(2-methoxyethyl)-2-({4-[2-(3- methoxyphenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 200 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450662 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450662&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609119 440826625 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924128 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cc2)C(F)(F)F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32F3N3O5/c1-31(22-7-9-23(10-8-22)32(33,34)35)42-27-5-3-4-24(29(27)43-31)20-12-14-37(15-13-20)19-28-36-25-11-6-21(30(39)40)18-26(25)38(28)16-17-41-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,39,40) DZNKPQWSJTYPNM-UHFFFAOYSA-N 450663 US10676465, Example 40::1-(2-methoxyethyl)-2-[(4-{2-methyl-2-[4- (trifluoromethyl)phenyl]-1,3-benzodioxol- 4-yl}piperidin-1-yl)methyl]-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 14.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450663&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608985 440826626 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924129 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cc2)C(F)(F)F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32F3N3O5/c1-31(22-7-9-23(10-8-22)32(33,34)35)42-27-5-3-4-24(29(27)43-31)20-12-14-37(15-13-20)19-28-36-25-11-6-21(30(39)40)18-26(25)38(28)16-17-41-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,39,40) DZNKPQWSJTYPNM-UHFFFAOYSA-N 450663 US10676465, Example 40::1-(2-methoxyethyl)-2-[(4-{2-methyl-2-[4- (trifluoromethyl)phenyl]-1,3-benzodioxol- 4-yl}piperidin-1-yl)methyl]-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 130 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450663&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608985 440826626 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924130 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(F)c(C)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O5/c1-20-17-23(8-9-25(20)33)32(2)40-28-6-4-5-24(30(28)41-32)21-11-13-35(14-12-21)19-29-34-26-10-7-22(31(37)38)18-27(26)36(29)15-16-39-3/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,37,38) YTIGSHWWBRLJCJ-UHFFFAOYSA-N 450664 US10676465, Example 41::2-({4-[2-(3,4-difluorophenyl)-2-methyl- 1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 91.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450664&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146651792 440826627 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924131 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(F)c(C)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34FN3O5/c1-20-17-23(8-9-25(20)33)32(2)40-28-6-4-5-24(30(28)41-32)21-11-13-35(14-12-21)19-29-34-26-10-7-22(31(37)38)18-27(26)36(29)15-16-39-3/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,37,38) YTIGSHWWBRLJCJ-UHFFFAOYSA-N 450664 US10676465, Example 41::2-({4-[2-(3,4-difluorophenyl)-2-methyl- 1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 2000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450664&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146651792 440826627 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924132 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(C)nc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34N4O5/c1-20-7-9-23(18-32-20)31(2)39-27-6-4-5-24(29(27)40-31)21-11-13-34(14-12-21)19-28-33-25-10-8-22(30(36)37)17-26(25)35(28)15-16-38-3/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,36,37) SBKGCYMQXFXCMN-UHFFFAOYSA-N 450665 US10676465, Example 42::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(6- methylpyridin-3-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 120 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450665&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608996 440826628 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924133 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(C)nc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34N4O5/c1-20-7-9-23(18-32-20)31(2)39-27-6-4-5-24(29(27)40-31)21-11-13-34(14-12-21)19-28-33-25-10-8-22(30(36)37)17-26(25)35(28)15-16-38-3/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,36,37) SBKGCYMQXFXCMN-UHFFFAOYSA-N 450665 US10676465, Example 42::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(6- methylpyridin-3-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 1700 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450665&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608996 440826628 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924134 CN(CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O)C(C)=O InChI=1S/C33H34ClFN4O5/c1-20(40)37(3)15-16-39-28-17-22(32(41)42)7-10-27(28)36-30(39)19-38-13-11-21(12-14-38)24-5-4-6-29-31(24)44-33(2,43-29)25-9-8-23(34)18-26(25)35/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,41,42) JTTJFZXVBJKPMI-UHFFFAOYSA-N 450666 US10676465, Example 43::1-{2-[acetyl(methyl)amino]ethyl}-2-({4-[2- (4-chloro-2-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 3.50 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450666&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609096 440826629 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924135 CN(CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O)C(C)=O InChI=1S/C33H34ClFN4O5/c1-20(40)37(3)15-16-39-28-17-22(32(41)42)7-10-27(28)36-30(39)19-38-13-11-21(12-14-38)24-5-4-6-29-31(24)44-33(2,43-29)25-9-8-23(34)18-26(25)35/h4-10,17-18,21H,11-16,19H2,1-3H3,(H,41,42) JTTJFZXVBJKPMI-UHFFFAOYSA-N 450666 US10676465, Example 43::1-{2-[acetyl(methyl)amino]ethyl}-2-({4-[2- (4-chloro-2-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 65.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450666&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609096 440826629 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924136 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCOCC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H36ClFN4O5/c1-34(26-7-6-24(35)20-27(26)36)44-30-4-2-3-25(32(30)45-34)22-9-11-39(12-10-22)21-31-37-28-8-5-23(33(41)42)19-29(28)40(31)14-13-38-15-17-43-18-16-38/h2-8,19-20,22H,9-18,21H2,1H3,(H,41,42) FZLPYDSBNKMBBV-UHFFFAOYSA-N 450667 US10676465, Example 44::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(morpholin-4-yl)ethyl]-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 160 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450667&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609169 440826630 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924137 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ccccn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H30ClFN4O4/c1-34(26-10-9-23(35)18-27(26)36)43-30-7-4-6-25(32(30)44-34)21-12-15-39(16-13-21)20-31-38-28-11-8-22(33(41)42)17-29(28)40(31)19-24-5-2-3-14-37-24/h2-11,14,17-18,21H,12-13,15-16,19-20H2,1H3,(H,41,42) HTPJVSOAINTYKD-UHFFFAOYSA-N 450668 US10676465, Example 45::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(pyridin-2-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 9.90 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450668&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609079 440826631 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924138 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ccccn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H30ClFN4O4/c1-34(26-10-9-23(35)18-27(26)36)43-30-7-4-6-25(32(30)44-34)21-12-15-39(16-13-21)20-31-38-28-11-8-22(33(41)42)17-29(28)40(31)19-24-5-2-3-14-37-24/h2-11,14,17-18,21H,12-13,15-16,19-20H2,1H3,(H,41,42) HTPJVSOAINTYKD-UHFFFAOYSA-N 450668 US10676465, Example 45::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(pyridin-2-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 220 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450668&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609079 440826631 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924139 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCOC4=O)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H32ClFN4O6/c1-33(24-7-6-22(34)18-25(24)35)44-28-4-2-3-23(30(28)45-33)20-9-11-37(12-10-20)19-29-36-26-8-5-21(31(40)41)17-27(26)39(29)14-13-38-15-16-43-32(38)42/h2-8,17-18,20H,9-16,19H2,1H3,(H,40,41) CTZFMGTXHZKRIM-UHFFFAOYSA-N 450669 US10676465, Example 46::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-oxo-1,3-oxazolidin-3- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 5.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450669&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609094 440826632 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924140 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCOC4=O)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H32ClFN4O6/c1-33(24-7-6-22(34)18-25(24)35)44-28-4-2-3-23(30(28)45-33)20-9-11-37(12-10-20)19-29-36-26-8-5-21(31(40)41)17-27(26)39(29)14-13-38-15-16-43-32(38)42/h2-8,17-18,20H,9-16,19H2,1H3,(H,40,41) CTZFMGTXHZKRIM-UHFFFAOYSA-N 450669 US10676465, Example 46::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-oxo-1,3-oxazolidin-3- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 57.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450669&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609094 440826632 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924141 CN(C)S(=O)(=O)CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O6S/c1-32(24-9-8-22(33)18-25(24)34)43-28-6-4-5-23(30(28)44-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)15-16-45(41,42)36(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) NLIZFFWMTNKUSI-UHFFFAOYSA-N 450670 US10676465, Example 47::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(dimethylsulfamoyl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 42.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450670&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609019 440826633 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924142 CN(C)S(=O)(=O)CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O6S/c1-32(24-9-8-22(33)18-25(24)34)43-28-6-4-5-23(30(28)44-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)15-16-45(41,42)36(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) NLIZFFWMTNKUSI-UHFFFAOYSA-N 450670 US10676465, Example 47::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(dimethylsulfamoyl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1400 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450670&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609019 440826633 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924143 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCCC4=O)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H34ClFN4O5/c1-34(25-9-8-23(35)19-26(25)36)44-29-5-2-4-24(32(29)45-34)21-11-14-38(15-12-21)20-30-37-27-10-7-22(33(42)43)18-28(27)40(30)17-16-39-13-3-6-31(39)41/h2,4-5,7-10,18-19,21H,3,6,11-17,20H2,1H3,(H,42,43) ULGPCGCUDRRRKS-UHFFFAOYSA-N 450671 US10676465, Example 48::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-oxopyrrolidin-1- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 14.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450671&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609083 440826634 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924144 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCCC4=O)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H34ClFN4O5/c1-34(25-9-8-23(35)19-26(25)36)44-29-5-2-4-24(32(29)45-34)21-11-14-38(15-12-21)20-30-37-27-10-7-22(33(42)43)18-28(27)40(30)17-16-39-13-3-6-31(39)41/h2,4-5,7-10,18-19,21H,3,6,11-17,20H2,1H3,(H,42,43) ULGPCGCUDRRRKS-UHFFFAOYSA-N 450671 US10676465, Example 48::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-oxopyrrolidin-1- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 280 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450671&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609083 440826634 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924145 CC(=O)NCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN4O5/c1-19(39)35-12-15-38-27-16-21(31(40)41)6-9-26(27)36-29(38)18-37-13-10-20(11-14-37)23-4-3-5-28-30(23)43-32(2,42-28)24-8-7-22(33)17-25(24)34/h3-9,16-17,20H,10-15,18H2,1-2H3,(H,35,39)(H,40,41) ZSAWIUDLQSYTLP-UHFFFAOYSA-N 450672 US10676465, Example 49::1-[2-(acetylamino)ethyl]-2-({4-[2-(4- chloro-2-fluorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 230 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450672 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450672&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609128 440826635 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924146 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCn4ccnc4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H31ClFN5O4/c1-33(25-7-6-23(34)18-26(25)35)43-29-4-2-3-24(31(29)44-33)21-9-12-38(13-10-21)19-30-37-27-8-5-22(32(41)42)17-28(27)40(30)16-15-39-14-11-36-20-39/h2-8,11,14,17-18,20-21H,9-10,12-13,15-16,19H2,1H3,(H,41,42) XRLRUOZIODRZPD-UHFFFAOYSA-N 450673 US10676465, Example 50::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1H-imidazol-1-yl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 12.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450673&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609042 440826636 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924147 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCn4ccnc4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H31ClFN5O4/c1-33(25-7-6-23(34)18-26(25)35)43-29-4-2-3-24(31(29)44-33)21-9-12-38(13-10-21)19-30-37-27-8-5-22(32(41)42)17-28(27)40(30)16-15-39-14-11-36-20-39/h2-8,11,14,17-18,20-21H,9-10,12-13,15-16,19H2,1H3,(H,41,42) XRLRUOZIODRZPD-UHFFFAOYSA-N 450673 US10676465, Example 50::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1H-imidazol-1-yl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 140 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450673&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609042 440826636 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924148 CCn1ccnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H33ClFN5O4/c1-3-40-16-13-37-30(40)20-41-28-17-22(33(42)43)7-10-27(28)38-31(41)19-39-14-11-21(12-15-39)24-5-4-6-29-32(24)45-34(2,44-29)25-9-8-23(35)18-26(25)36/h4-10,13,16-18,21H,3,11-12,14-15,19-20H2,1-2H3,(H,42,43) WFAXSLMVFZOJOH-UHFFFAOYSA-N 450674 US10676465, Example 51::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-ethyl-1H-imidazol-2- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 19.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450674&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609059 440826637 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924149 CCn1ccnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H33ClFN5O4/c1-3-40-16-13-37-30(40)20-41-28-17-22(33(42)43)7-10-27(28)38-31(41)19-39-14-11-21(12-15-39)24-5-4-6-29-32(24)45-34(2,44-29)25-9-8-23(35)18-26(25)36/h4-10,13,16-18,21H,3,11-12,14-15,19-20H2,1-2H3,(H,42,43) WFAXSLMVFZOJOH-UHFFFAOYSA-N 450674 US10676465, Example 51::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-ethyl-1H-imidazol-2- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 280 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450674&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609059 440826637 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924150 CNC(=O)Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN4O5/c1-31(22-8-7-20(32)15-23(22)33)41-26-5-3-4-21(29(26)42-31)18-10-12-36(13-11-18)16-27-35-24-9-6-19(30(39)40)14-25(24)37(27)17-28(38)34-2/h3-9,14-15,18H,10-13,16-17H2,1-2H3,(H,34,38)(H,39,40) VVIVEHANPPRKLZ-UHFFFAOYSA-N 450675 US10676465, Example 52::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(methylamino)-2- oxoethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 32.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450675&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609036 440826638 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924151 CNC(=O)Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN4O5/c1-31(22-8-7-20(32)15-23(22)33)41-26-5-3-4-21(29(26)42-31)18-10-12-36(13-11-18)16-27-35-24-9-6-19(30(39)40)14-25(24)37(27)17-28(38)34-2/h3-9,14-15,18H,10-13,16-17H2,1-2H3,(H,34,38)(H,39,40) VVIVEHANPPRKLZ-UHFFFAOYSA-N 450675 US10676465, Example 52::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(methylamino)-2- oxoethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 570 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450675&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609036 440826638 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924152 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCn4cccn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H31ClFN5O4/c1-33(25-8-7-23(34)19-26(25)35)43-29-5-2-4-24(31(29)44-33)21-10-14-38(15-11-21)20-30-37-27-9-6-22(32(41)42)18-28(27)40(30)17-16-39-13-3-12-36-39/h2-9,12-13,18-19,21H,10-11,14-17,20H2,1H3,(H,41,42) RRKHSNBDKFXHJD-UHFFFAOYSA-N 450676 US10676465, Example 53::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1H-pyrazol-1-yl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 3.10 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450676&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609082 440826639 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924153 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCn4cccn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H31ClFN5O4/c1-33(25-8-7-23(34)19-26(25)35)43-29-5-2-4-24(31(29)44-33)21-10-14-38(15-11-21)20-30-37-27-9-6-22(32(41)42)18-28(27)40(30)17-16-39-13-3-12-36-39/h2-9,12-13,18-19,21H,10-11,14-17,20H2,1H3,(H,41,42) RRKHSNBDKFXHJD-UHFFFAOYSA-N 450676 US10676465, Example 53::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1H-pyrazol-1-yl)ethyl]- 1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 52.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450676&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609082 440826639 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924154 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCCn4cncn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H32ClFN6O4/c1-33(25-8-7-23(34)17-26(25)35)44-29-5-2-4-24(31(29)45-33)21-10-14-39(15-11-21)18-30-38-27-9-6-22(32(42)43)16-28(27)41(30)13-3-12-40-20-36-19-37-40/h2,4-9,16-17,19-21H,3,10-15,18H2,1H3,(H,42,43) CGHHJFXIUNRBIY-UHFFFAOYSA-N 450677 US10676465, Example 54::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[3-(1H-1,2,4-triazol-1- yl)propyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 18.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450677&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609028 440826640 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924155 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCCn4cncn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H32ClFN6O4/c1-33(25-8-7-23(34)17-26(25)35)44-29-5-2-4-24(31(29)45-33)21-10-14-39(15-11-21)18-30-38-27-9-6-22(32(42)43)16-28(27)41(30)13-3-12-40-20-36-19-37-40/h2,4-9,16-17,19-21H,3,10-15,18H2,1H3,(H,42,43) CGHHJFXIUNRBIY-UHFFFAOYSA-N 450677 US10676465, Example 54::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[3-(1H-1,2,4-triazol-1- yl)propyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 160 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450677&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609028 440826640 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924156 Cn1cnc(CCn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C34H33ClFN5O4/c1-34(26-8-7-23(35)17-27(26)36)44-30-5-3-4-25(32(30)45-34)21-10-13-40(14-11-21)19-31-38-28-9-6-22(33(42)43)16-29(28)41(31)15-12-24-18-39(2)20-37-24/h3-9,16-18,20-21H,10-15,19H2,1-2H3,(H,42,43) ZNUVUVLMHLNNDK-UHFFFAOYSA-N 450678 US10676465, Example 55::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1-methyl-1H-imidazol-4- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 74.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450678&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608990 440826641 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924157 Cn1cnc(CCn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C34H33ClFN5O4/c1-34(26-8-7-23(35)17-27(26)36)44-30-5-3-4-25(32(30)45-34)21-10-13-40(14-11-21)19-31-38-28-9-6-22(33(42)43)16-29(28)41(31)15-12-24-18-39(2)20-37-24/h3-9,16-18,20-21H,10-15,19H2,1-2H3,(H,42,43) ZNUVUVLMHLNNDK-UHFFFAOYSA-N 450678 US10676465, Example 55::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1-methyl-1H-imidazol-4- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1100 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450678&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608990 440826641 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924158 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CC4CCOC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H33ClFN3O5/c1-33(25-7-6-23(34)16-26(25)35)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)18-30-36-27-8-5-22(32(39)40)15-28(27)38(30)17-20-11-14-41-19-20/h2-8,15-16,20-21H,9-14,17-19H2,1H3,(H,39,40) QFWZJZFFWRDNNB-UHFFFAOYSA-N 450679 US10676465, Example 56::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(tetrahydrofuran-3- ylmethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450679&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609016 440826642 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924159 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CC4CCOC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H33ClFN3O5/c1-33(25-7-6-23(34)16-26(25)35)42-29-4-2-3-24(31(29)43-33)21-9-12-37(13-10-21)18-30-36-27-8-5-22(32(39)40)15-28(27)38(30)17-20-11-14-41-19-20/h2-8,15-16,20-21H,9-14,17-19H2,1H3,(H,39,40) QFWZJZFFWRDNNB-UHFFFAOYSA-N 450679 US10676465, Example 56::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(tetrahydrofuran-3- ylmethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 11.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450679&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609016 440826642 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924160 Cn1ncnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H30ClFN6O4/c1-32(23-8-7-21(33)15-24(23)34)43-27-5-3-4-22(30(27)44-32)19-10-12-39(13-11-19)16-29-37-25-9-6-20(31(41)42)14-26(25)40(29)17-28-35-18-36-38(28)2/h3-9,14-15,18-19H,10-13,16-17H2,1-2H3,(H,41,42) GVZSRCWZTZLHCO-UHFFFAOYSA-N 450680 US10676465, Example 57::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-1,2,4-triazol- 5-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 15.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450680&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608989 440826643 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924161 Cn1ncnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H30ClFN6O4/c1-32(23-8-7-21(33)15-24(23)34)43-27-5-3-4-22(30(27)44-32)19-10-12-39(13-11-19)16-29-37-25-9-6-20(31(41)42)14-26(25)40(29)17-28-35-18-36-38(28)2/h3-9,14-15,18-19H,10-13,16-17H2,1-2H3,(H,41,42) GVZSRCWZTZLHCO-UHFFFAOYSA-N 450680 US10676465, Example 57::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-1,2,4-triazol- 5-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 500 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450680&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608989 440826643 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924162 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cocn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(24-7-6-21(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)19-9-11-37(12-10-19)16-29-36-26-8-5-20(31(39)40)13-27(26)38(29)15-22-17-41-18-35-22/h2-8,13-14,17-19H,9-12,15-16H2,1H3,(H,39,40) DCMQZEXHKANJOV-UHFFFAOYSA-N 450681 US10676465, Example 58::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-4-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 4.00 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450681&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608997 440826644 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924163 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cocn4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(24-7-6-21(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)19-9-11-37(12-10-19)16-29-36-26-8-5-20(31(39)40)13-27(26)38(29)15-22-17-41-18-35-22/h2-8,13-14,17-19H,9-12,15-16H2,1H3,(H,39,40) DCMQZEXHKANJOV-UHFFFAOYSA-N 450681 US10676465, Example 58::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-4-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 23.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450681&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608997 440826644 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924164 CN(C)C(=O)CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C33H34ClFN4O5/c1-33(24-9-8-22(34)18-25(24)35)43-28-6-4-5-23(31(28)44-33)20-11-14-38(15-12-20)19-29-36-26-10-7-21(32(41)42)17-27(26)39(29)16-13-30(40)37(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,41,42) FNLKHZMZPCXUQZ-UHFFFAOYSA-N 450682 US10676465, Example 59::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[3-(dimethylamino)-3- oxopropyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 74.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450682&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609146 440826645 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924165 CN(C)C(=O)CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C33H34ClFN4O5/c1-33(24-9-8-22(34)18-25(24)35)43-28-6-4-5-23(31(28)44-33)20-11-14-38(15-12-20)19-29-36-26-10-7-21(32(41)42)17-27(26)39(29)16-13-30(40)37(2)3/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,41,42) FNLKHZMZPCXUQZ-UHFFFAOYSA-N 450682 US10676465, Example 59::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[3-(dimethylamino)-3- oxopropyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 680 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450682&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609146 440826645 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924166 Cn1cc(CCn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C33H32ClFN6O4/c1-33(25-8-7-22(34)17-26(25)35)44-29-5-3-4-24(31(29)45-33)20-10-13-40(14-11-20)19-30-36-27-9-6-21(32(42)43)16-28(27)41(30)15-12-23-18-39(2)38-37-23/h3-9,16-18,20H,10-15,19H2,1-2H3,(H,42,43) VHYQGSJCIAGSJM-UHFFFAOYSA-N 450683 US10676465, Example 60::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1-methyl-1H-1,2,3- triazol-4-yl)ethyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 15.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450683&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609039 440826646 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924167 Cn1cc(CCn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C33H32ClFN6O4/c1-33(25-8-7-22(34)17-26(25)35)44-29-5-3-4-24(31(29)45-33)20-10-13-40(14-11-20)19-30-36-27-9-6-21(32(42)43)16-28(27)41(30)15-12-23-18-39(2)38-37-23/h3-9,16-18,20H,10-15,19H2,1-2H3,(H,42,43) VHYQGSJCIAGSJM-UHFFFAOYSA-N 450683 US10676465, Example 60::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1-methyl-1H-1,2,3- triazol-4-yl)ethyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 240 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450683&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609039 440826646 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924168 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C4CCOC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)17-29-35-26-8-5-20(31(38)39)15-27(26)37(29)22-11-14-40-18-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39) UIABPYLSPINEKX-UHFFFAOYSA-N 450684 US10676465, Example 61::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(tetrahydrofuran-3-yl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 10.00 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450684&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609069 440826647 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924169 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C4CCOC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H31ClFN3O5/c1-32(24-7-6-21(33)16-25(24)34)41-28-4-2-3-23(30(28)42-32)19-9-12-36(13-10-19)17-29-35-26-8-5-20(31(38)39)15-27(26)37(29)22-11-14-40-18-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,38,39) UIABPYLSPINEKX-UHFFFAOYSA-N 450684 US10676465, Example 61::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(tetrahydrofuran-3-yl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 240 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450684&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609069 440826647 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924170 Cc1nccn1CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H33ClFN5O4/c1-21-37-12-15-40(21)16-17-41-29-18-23(33(42)43)6-9-28(29)38-31(41)20-39-13-10-22(11-14-39)25-4-3-5-30-32(25)45-34(2,44-30)26-8-7-24(35)19-27(26)36/h3-9,12,15,18-19,22H,10-11,13-14,16-17,20H2,1-2H3,(H,42,43) NVJXLLRDHOIAHD-UHFFFAOYSA-N 450685 US10676465, Example 62::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-methyl-1H-imidazol-1- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 2.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450685&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609118 440826648 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924171 Cc1nccn1CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H33ClFN5O4/c1-21-37-12-15-40(21)16-17-41-29-18-23(33(42)43)6-9-28(29)38-31(41)20-39-13-10-22(11-14-39)25-4-3-5-30-32(25)45-34(2,44-30)26-8-7-24(35)19-27(26)36/h3-9,12,15,18-19,22H,10-11,13-14,16-17,20H2,1-2H3,(H,42,43) NVJXLLRDHOIAHD-UHFFFAOYSA-N 450685 US10676465, Example 62::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(2-methyl-1H-imidazol-1- yl)ethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 82.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450685&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609118 440826648 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924172 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C32H30ClFN6O4/c1-32(24-8-7-21(33)15-25(24)34)43-28-5-3-4-23(30(28)44-32)19-10-12-39(13-11-19)18-29-35-26-9-6-20(31(41)42)14-27(26)40(29)17-22-16-38(2)37-36-22/h3-9,14-16,19H,10-13,17-18H2,1-2H3,(H,41,42) BKWFIGDPQMYDHP-UHFFFAOYSA-N 450686 US10676465, Example 63::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-1,2,3-triazol- 4-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 5.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450686&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609001 440826649 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924173 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C32H30ClFN6O4/c1-32(24-8-7-21(33)15-25(24)34)43-28-5-3-4-23(30(28)44-32)19-10-12-39(13-11-19)18-29-35-26-9-6-20(31(41)42)14-27(26)40(29)17-22-16-38(2)37-36-22/h3-9,14-16,19H,10-13,17-18H2,1-2H3,(H,41,42) BKWFIGDPQMYDHP-UHFFFAOYSA-N 450686 US10676465, Example 63::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-1,2,3-triazol- 4-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 66.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450686&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609001 440826649 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924174 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@H]4CCCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-33(25-9-8-22(34)17-26(25)35)42-29-6-2-5-24(31(29)43-33)20-11-13-37(14-12-20)19-30-36-27-10-7-21(32(39)40)16-28(27)38(30)18-23-4-3-15-41-23/h2,5-10,16-17,20,23H,3-4,11-15,18-19H2,1H3,(H,39,40) QWQGZVWJNYHQMH-UHFFFAOYSA-N 450687 US10676465, Example 64::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(2R)-tetrahydrofuran-2- ylmethyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 9.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450687&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609109 440826650 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924175 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@H]4CCCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-33(25-9-8-22(34)17-26(25)35)42-29-6-2-5-24(31(29)43-33)20-11-13-37(14-12-20)19-30-36-27-10-7-21(32(39)40)16-28(27)38(30)18-23-4-3-15-41-23/h2,5-10,16-17,20,23H,3-4,11-15,18-19H2,1H3,(H,39,40) QWQGZVWJNYHQMH-UHFFFAOYSA-N 450687 US10676465, Example 64::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(2R)-tetrahydrofuran-2- ylmethyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 91.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450687&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609109 440826650 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924176 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cccnc4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H30ClFN4O4/c1-34(26-9-8-24(35)17-27(26)36)43-30-6-2-5-25(32(30)44-34)22-11-14-39(15-12-22)20-31-38-28-10-7-23(33(41)42)16-29(28)40(31)19-21-4-3-13-37-18-21/h2-10,13,16-18,22H,11-12,14-15,19-20H2,1H3,(H,41,42) RWXJNGGSPJLQJH-UHFFFAOYSA-N 450688 US10676465, Example 65::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(pyridin-3-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450688&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609044 440826651 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924177 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cccnc4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H30ClFN4O4/c1-34(26-9-8-24(35)17-27(26)36)43-30-6-2-5-25(32(30)44-34)22-11-14-39(15-12-22)20-31-38-28-10-7-23(33(41)42)16-29(28)40(31)19-21-4-3-13-37-18-21/h2-10,13,16-18,22H,11-12,14-15,19-20H2,1H3,(H,41,42) RWXJNGGSPJLQJH-UHFFFAOYSA-N 450688 US10676465, Example 65::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(pyridin-3-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 11.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450688&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609044 440826651 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924178 CN(C)C(=O)Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN4O5/c1-32(23-9-8-21(33)16-24(23)34)42-27-6-4-5-22(30(27)43-32)19-11-13-37(14-12-19)17-28-35-25-10-7-20(31(40)41)15-26(25)38(28)18-29(39)36(2)3/h4-10,15-16,19H,11-14,17-18H2,1-3H3,(H,40,41) BVMVJWOSROAMGV-UHFFFAOYSA-N 450689 US10676465, Example 66::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(dimethylamino)-2- oxoethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 51.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450689&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609133 440826652 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924179 CN(C)C(=O)Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN4O5/c1-32(23-9-8-21(33)16-24(23)34)42-27-6-4-5-22(30(27)43-32)19-11-13-37(14-12-19)17-28-35-25-10-7-20(31(40)41)15-26(25)38(28)18-29(39)36(2)3/h4-10,15-16,19H,11-14,17-18H2,1-3H3,(H,40,41) BVMVJWOSROAMGV-UHFFFAOYSA-N 450689 US10676465, Example 66::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(dimethylamino)-2- oxoethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 850 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450689&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609133 440826652 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924180 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCN4CCCC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C34H36ClFN4O4/c1-34(26-9-8-24(35)20-27(26)36)43-30-6-4-5-25(32(30)44-34)22-11-15-39(16-12-22)21-31-37-28-10-7-23(33(41)42)19-29(28)40(31)18-17-38-13-2-3-14-38/h4-10,19-20,22H,2-3,11-18,21H2,1H3,(H,41,42) JMTOBDSBMMQVKD-UHFFFAOYSA-N 450690 US10676465, Example 67::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(pyrrolidin-1-yl)ethyl]-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 710 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450690 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450690&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609027 440826653 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924181 COCc1cc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)[nH]n1 InChI=1S/C34H33ClFN5O5/c1-34(26-8-7-22(35)15-27(26)36)45-30-5-3-4-25(32(30)46-34)20-10-12-40(13-11-20)18-31-37-28-9-6-21(33(42)43)14-29(28)41(31)17-23-16-24(19-44-2)39-38-23/h3-9,14-16,20H,10-13,17-19H2,1-2H3,(H,38,39)(H,42,43) JTAIVEMGPZYQSN-UHFFFAOYSA-N 450691 US10676465, Example 68::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{[3-(methoxymethyl)-1H- pyrazol-5-yl]methyl}-1H-benzimidazole- 6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 73.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450691&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609137 440826654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924182 COCc1cc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)[nH]n1 InChI=1S/C34H33ClFN5O5/c1-34(26-8-7-22(35)15-27(26)36)45-30-5-3-4-25(32(30)46-34)20-10-12-40(13-11-20)18-31-37-28-9-6-21(33(42)43)14-29(28)41(31)17-23-16-24(19-44-2)39-38-23/h3-9,14-16,20H,10-13,17-19H2,1-2H3,(H,38,39)(H,42,43) JTAIVEMGPZYQSN-UHFFFAOYSA-N 450691 US10676465, Example 68::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{[3-(methoxymethyl)-1H- pyrazol-5-yl]methyl}-1H-benzimidazole- 6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1200 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450691&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609137 440826654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924183 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cnco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(24-7-6-21(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)19-9-11-37(12-10-19)17-29-36-26-8-5-20(31(39)40)13-27(26)38(29)16-22-15-35-18-41-22/h2-8,13-15,18-19H,9-12,16-17H2,1H3,(H,39,40) QPYNBMHQTDUXIA-UHFFFAOYSA-N 450692 US10676465, Example 69::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-5-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 10.00 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450692&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609045 440826655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924184 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cnco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(24-7-6-21(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)19-9-11-37(12-10-19)17-29-36-26-8-5-20(31(39)40)13-27(26)38(29)16-22-15-35-18-41-22/h2-8,13-15,18-19H,9-12,16-17H2,1H3,(H,39,40) QPYNBMHQTDUXIA-UHFFFAOYSA-N 450692 US10676465, Example 69::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-5-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 8.30 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450692&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609045 440826655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924185 COCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H34ClFN6O5/c1-34(25-8-7-23(35)17-26(25)36)46-29-5-3-4-24(32(29)47-34)21-10-12-40(13-11-21)18-30-38-27-9-6-22(33(43)44)16-28(27)42(30)19-31-39-37-20-41(31)14-15-45-2/h3-9,16-17,20-21H,10-15,18-19H2,1-2H3,(H,43,44) YNSQSAPSJKFFRZ-UHFFFAOYSA-N 450693 US10676465, Example 70::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{[4-(2-methoxyethyl)-4H- 1,2,4-triazol-3-yl]methyl}-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 2.80 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450693&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609029 440826656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924186 COCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C34H34ClFN6O5/c1-34(25-8-7-23(35)17-26(25)36)46-29-5-3-4-24(32(29)47-34)21-10-12-40(13-11-21)18-30-38-27-9-6-22(33(43)44)16-28(27)42(30)19-31-39-37-20-41(31)14-15-45-2/h3-9,16-17,20-21H,10-15,18-19H2,1-2H3,(H,43,44) YNSQSAPSJKFFRZ-UHFFFAOYSA-N 450693 US10676465, Example 70::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{[4-(2-methoxyethyl)-4H- 1,2,4-triazol-3-yl]methyl}-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 97.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450693&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609029 440826656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924187 CN(CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O)S(C)(=O)=O InChI=1S/C32H34ClFN4O6S/c1-32(24-9-8-22(33)18-25(24)34)43-28-6-4-5-23(30(28)44-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)16-15-36(2)45(3,41)42/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) JPDYSRPXQGWKCK-UHFFFAOYSA-N 450694 US10676465, Example 71::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{2- [methyl(methylsulfonyl)amino]ethyl}-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 6.80 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450694&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609065 440826657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924188 CN(CCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O)S(C)(=O)=O InChI=1S/C32H34ClFN4O6S/c1-32(24-9-8-22(33)18-25(24)34)43-28-6-4-5-23(30(28)44-32)20-11-13-37(14-12-20)19-29-35-26-10-7-21(31(39)40)17-27(26)38(29)16-15-36(2)45(3,41)42/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,39,40) JPDYSRPXQGWKCK-UHFFFAOYSA-N 450694 US10676465, Example 71::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-{2- [methyl(methylsulfonyl)amino]ethyl}-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 74.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450694&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609065 440826657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924189 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CC4(O)CCC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H33ClFN3O5/c1-32(24-8-7-22(34)17-25(24)35)42-28-5-2-4-23(30(28)43-32)20-10-14-37(15-11-20)18-29-36-26-9-6-21(31(39)40)16-27(26)38(29)19-33(41)12-3-13-33/h2,4-9,16-17,20,41H,3,10-15,18-19H2,1H3,(H,39,40) AYSYLGGLKYFVND-UHFFFAOYSA-N 450695 US10676465, Example 72::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1- hydroxycyclobutyl)methyl]-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 14.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450695&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609158 440826658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924190 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CC4(O)CCC4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H33ClFN3O5/c1-32(24-8-7-22(34)17-25(24)35)42-28-5-2-4-23(30(28)43-32)20-10-14-37(15-11-20)18-29-36-26-9-6-21(31(39)40)16-27(26)38(29)19-33(41)12-3-13-33/h2,4-9,16-17,20,41H,3,10-15,18-19H2,1H3,(H,39,40) AYSYLGGLKYFVND-UHFFFAOYSA-N 450695 US10676465, Example 72::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1- hydroxycyclobutyl)methyl]-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 310 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450695&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609158 440826658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924191 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cn[nH]c4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H29ClFN5O4/c1-32(24-7-6-22(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)20-9-11-38(12-10-20)18-29-37-26-8-5-21(31(40)41)13-27(26)39(29)17-19-15-35-36-16-19/h2-8,13-16,20H,9-12,17-18H2,1H3,(H,35,36)(H,40,41) KGNVGFGGRSAXKA-UHFFFAOYSA-N 450696 US10676465, Example 73::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1H-pyrazol-4-ylmethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 1.70 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450696&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609055 440826659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924192 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4cn[nH]c4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H29ClFN5O4/c1-32(24-7-6-22(33)14-25(24)34)42-28-4-2-3-23(30(28)43-32)20-9-11-38(12-10-20)18-29-37-26-8-5-21(31(40)41)13-27(26)39(29)17-19-15-35-36-16-19/h2-8,13-16,20H,9-12,17-18H2,1H3,(H,35,36)(H,40,41) KGNVGFGGRSAXKA-UHFFFAOYSA-N 450696 US10676465, Example 73::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1H-pyrazol-4-ylmethyl)-1H- benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 10.00 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450696&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609055 440826659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924193 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCc4ncc[nH]4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C33H31ClFN5O4/c1-33(24-7-6-22(34)18-25(24)35)43-28-4-2-3-23(31(28)44-33)20-9-14-39(15-10-20)19-30-38-26-8-5-21(32(41)42)17-27(26)40(30)16-11-29-36-12-13-37-29/h2-8,12-13,17-18,20H,9-11,14-16,19H2,1H3,(H,36,37)(H,41,42) SKWUVGSPQQIXJK-UHFFFAOYSA-N 450697 US10676465, Example 74::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[2-(1H-imidazol-2-yl)ethyl]- 1H-benzimidazole-6-carboxylic acid, trifluoroacetate salt Glucagon-like peptide 1 receptor Homo sapiens 460 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450697&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608992 440826660 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924194 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCO)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C30H29ClFN3O5/c1-30(22-7-6-20(31)16-23(22)32)39-26-4-2-3-21(28(26)40-30)18-9-11-34(12-10-18)17-27-33-24-8-5-19(29(37)38)15-25(24)35(27)13-14-36/h2-8,15-16,18,36H,9-14,17H2,1H3,(H,37,38) NOSBPQDEANQDMQ-UHFFFAOYSA-N 450698 US10676465, Example 75::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-hydroxyethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 65.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450698&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609107 440826661 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924195 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4CCO)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C30H29ClFN3O5/c1-30(22-7-6-20(31)16-23(22)32)39-26-4-2-3-21(28(26)40-30)18-9-11-34(12-10-18)17-27-33-24-8-5-19(29(37)38)15-25(24)35(27)13-14-36/h2-8,15-16,18,36H,9-14,17H2,1H3,(H,37,38) NOSBPQDEANQDMQ-UHFFFAOYSA-N 450698 US10676465, Example 75::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-hydroxyethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450698&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609107 440826661 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924196 CCn1nncc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C33H32ClFN6O4/c1-3-41-23(17-36-38-41)18-40-28-15-21(32(42)43)7-10-27(28)37-30(40)19-39-13-11-20(12-14-39)24-5-4-6-29-31(24)45-33(2,44-29)25-9-8-22(34)16-26(25)35/h4-10,15-17,20H,3,11-14,18-19H2,1-2H3,(H,42,43) ZWHKAWIULYUCFU-UHFFFAOYSA-N 450700 US10676465, Example 76::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-ethyl-1H-1,2,3-triazol-5- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 0.770 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450700&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609032 440826663 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924197 CCn1nncc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C33H32ClFN6O4/c1-3-41-23(17-36-38-41)18-40-28-15-21(32(42)43)7-10-27(28)37-30(40)19-39-13-11-20(12-14-39)24-5-4-6-29-31(24)45-33(2,44-29)25-9-8-22(34)16-26(25)35/h4-10,15-17,20H,3,11-14,18-19H2,1-2H3,(H,42,43) ZWHKAWIULYUCFU-UHFFFAOYSA-N 450700 US10676465, Example 76::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-ethyl-1H-1,2,3-triazol-5- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 7.60 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450700&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609032 440826663 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924198 Cn1cnc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C33H31ClFN5O4/c1-33(25-8-7-22(34)15-26(25)35)43-29-5-3-4-24(31(29)44-33)20-10-12-39(13-11-20)18-30-37-27-9-6-21(32(41)42)14-28(27)40(30)17-23-16-38(2)19-36-23/h3-9,14-16,19-20H,10-13,17-18H2,1-2H3,(H,41,42) KYKWPZJRCFETAA-UHFFFAOYSA-N 450701 US10676465, Example 77::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-imidazol-4- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 53.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450701&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609122 440826664 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924199 Cn1cnc(Cn2c(CN3CCC(CC3)c3cccc4OC(C)(Oc34)c3ccc(Cl)cc3F)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C33H31ClFN5O4/c1-33(25-8-7-22(34)15-26(25)35)43-29-5-3-4-24(31(29)44-33)20-10-12-39(13-11-20)18-30-37-27-9-6-21(32(41)42)14-28(27)40(30)17-23-16-38(2)19-36-23/h3-9,14-16,19-20H,10-13,17-18H2,1-2H3,(H,41,42) KYKWPZJRCFETAA-UHFFFAOYSA-N 450701 US10676465, Example 77::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(1-methyl-1H-imidazol-4- yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1700 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450701&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609122 440826664 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924200 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H30ClFN6O4/c1-32(23-8-7-21(33)15-24(23)34)43-27-5-3-4-22(30(27)44-32)19-10-12-39(13-11-19)16-28-36-25-9-6-20(31(41)42)14-26(25)40(28)17-29-37-35-18-38(29)2/h3-9,14-15,18-19H,10-13,16-17H2,1-2H3,(H,41,42) RGCIHIAMOURMIC-UHFFFAOYSA-N 450702 US10676465, Example 78::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(4-methyl-4H-1,2,4-triazol- 3-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 4.50 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450702&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609064 440826665 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924201 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cc2F)nc2ccc(cc12)C(O)=O InChI=1S/C32H30ClFN6O4/c1-32(23-8-7-21(33)15-24(23)34)43-27-5-3-4-22(30(27)44-32)19-10-12-39(13-11-19)16-28-36-25-9-6-20(31(41)42)14-26(25)40(28)17-29-37-35-18-38(29)2/h3-9,14-15,18-19H,10-13,16-17H2,1-2H3,(H,41,42) RGCIHIAMOURMIC-UHFFFAOYSA-N 450702 US10676465, Example 78::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(4-methyl-4H-1,2,4-triazol- 3-yl)methyl]-1H-benzimidazole-6- carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 78.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450702&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609064 440826665 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924202 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-33(25-9-8-22(34)17-26(25)35)42-29-6-2-5-24(31(29)43-33)20-11-13-37(14-12-20)19-30-36-27-10-7-21(32(39)40)16-28(27)38(30)18-23-4-3-15-41-23/h2,5-10,16-17,20,23H,3-4,11-15,18-19H2,1H3,(H,39,40) QWQGZVWJNYHQMH-UHFFFAOYSA-N 450703 US10676465, Example 79::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(2S)-tetrahydrofuran-2- ylmethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1.40 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450703&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609047 440826666 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924203 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C33H33ClFN3O5/c1-33(25-9-8-22(34)17-26(25)35)42-29-6-2-5-24(31(29)43-33)20-11-13-37(14-12-20)19-30-36-27-10-7-21(32(39)40)16-28(27)38(30)18-23-4-3-15-41-23/h2,5-10,16-17,20,23H,3-4,11-15,18-19H2,1H3,(H,39,40) QWQGZVWJNYHQMH-UHFFFAOYSA-N 450703 US10676465, Example 79::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-[(2S)-tetrahydrofuran-2- ylmethyl]-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 21.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450703&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609047 440826666 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924204 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(23-7-6-21(33)16-24(23)34)42-27-4-2-3-22(30(27)43-32)19-9-12-37(13-10-19)17-28-36-25-8-5-20(31(39)40)15-26(25)38(28)18-29-35-11-14-41-29/h2-8,11,14-16,19H,9-10,12-13,17-18H2,1H3,(H,39,40) ACCVHTRNZBMGKN-UHFFFAOYSA-N 450704 US10676465, Example 80::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-2-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 1.10 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450704&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609100 440826667 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924205 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C32H28ClFN4O5/c1-32(23-7-6-21(33)16-24(23)34)42-27-4-2-3-22(30(27)43-32)19-9-12-37(13-10-19)17-28-36-25-8-5-20(31(39)40)15-26(25)38(28)18-29-35-11-14-41-29/h2-8,11,14-16,19H,9-10,12-13,17-18H2,1H3,(H,39,40) ACCVHTRNZBMGKN-UHFFFAOYSA-N 450704 US10676465, Example 80::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(1,3-oxazol-2-ylmethyl)-1H- benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 6.90 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450704&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609100 440826667 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924206 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(nc5n4Cc4cnco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C31H27ClFN5O5/c1-31(22-6-5-19(32)13-23(22)33)42-26-4-2-3-21(28(26)43-31)18-9-11-37(12-10-18)16-27-35-24-7-8-25(30(39)40)36-29(24)38(27)15-20-14-34-17-41-20/h2-8,13-14,17-18H,9-12,15-16H2,1H3,(H,39,40) JOAMMCYCDOREJD-UHFFFAOYSA-N 450705 US10676465, Example 81::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-3-(1,3-oxazol-5-ylmethyl)-3H- imidazo[4,5-b]pyridine-5-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 29.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450705&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609140 440826668 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924207 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(nc5n4Cc4cnco4)C(O)=O)CC3)c2O1)c1ccc(Cl)cc1F InChI=1S/C31H27ClFN5O5/c1-31(22-6-5-19(32)13-23(22)33)42-26-4-2-3-21(28(26)43-31)18-9-11-37(12-10-18)16-27-35-24-7-8-25(30(39)40)36-29(24)38(27)15-20-14-34-17-41-20/h2-8,13-14,17-18H,9-12,15-16H2,1H3,(H,39,40) JOAMMCYCDOREJD-UHFFFAOYSA-N 450705 US10676465, Example 81::2-({4-[2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-3-(1,3-oxazol-5-ylmethyl)-3H- imidazo[4,5-b]pyridine-5-carboxylic acid Glucagon-like peptide 1 receptor Homo sapiens 54.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450705&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609140 440826668 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924208 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33N3O5/c1-31(23-7-4-3-5-8-23)38-27-10-6-9-24(29(27)39-31)21-13-15-33(16-14-21)20-28-32-25-12-11-22(30(35)36)19-26(25)34(28)17-18-37-2/h3-12,19,21H,13-18,20H2,1-2H3,(H,35,36) LWIBTDQECQUSDK-UHFFFAOYSA-N 450706 US10676465, Example 82::1-(2-methoxyethyl)-2-{[4-(2-methyl-2- phenyl-1,3-benzodioxol-4-yl)piperidin-1- yl]methyl}-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 47.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450706&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609145 440826669 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924209 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33N3O5/c1-31(23-7-4-3-5-8-23)38-27-10-6-9-24(29(27)39-31)21-13-15-33(16-14-21)20-28-32-25-12-11-22(30(35)36)19-26(25)34(28)17-18-37-2/h3-12,19,21H,13-18,20H2,1-2H3,(H,35,36) LWIBTDQECQUSDK-UHFFFAOYSA-N 450706 US10676465, Example 82::1-(2-methoxyethyl)-2-{[4-(2-methyl-2- phenyl-1,3-benzodioxol-4-yl)piperidin-1- yl]methyl}-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 1000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450706&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609145 440826669 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924210 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2Cl)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClN3O6/c1-32(24-9-8-22(40-3)18-25(24)33)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-26-10-7-21(31(37)38)17-27(26)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) OFXFQZYZOYBUDV-UHFFFAOYSA-N 450707 US10676465, Example 83::2-({4-[2-(2-chloro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 3.40 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450707&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608987 440826670 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924211 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(OC)cc2Cl)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClN3O6/c1-32(24-9-8-22(40-3)18-25(24)33)41-28-6-4-5-23(30(28)42-32)20-11-13-35(14-12-20)19-29-34-26-10-7-21(31(37)38)17-27(26)36(29)15-16-39-2/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,37,38) OFXFQZYZOYBUDV-UHFFFAOYSA-N 450707 US10676465, Example 83::2-({4-[2-(2-chloro-4-methoxyphenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-1-(2-methoxyethyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 44.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450707&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608987 440826670 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924212 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(C)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O5/c1-21-7-10-24(11-8-21)32(2)39-28-6-4-5-25(30(28)40-32)22-13-15-34(16-14-22)20-29-33-26-12-9-23(31(36)37)19-27(26)35(29)17-18-38-3/h4-12,19,22H,13-18,20H2,1-3H3,(H,36,37) HHFUKSUWDLTSEI-UHFFFAOYSA-N 450708 US10676465, Example 84::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(4- methylphenyl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 9.10 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450708&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609144 440826671 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924213 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(C)cc2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O5/c1-21-7-10-24(11-8-21)32(2)39-28-6-4-5-25(30(28)40-32)22-13-15-34(16-14-22)20-29-33-26-12-9-23(31(36)37)19-27(26)35(29)17-18-38-3/h4-12,19,22H,13-18,20H2,1-3H3,(H,36,37) HHFUKSUWDLTSEI-UHFFFAOYSA-N 450708 US10676465, Example 84::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(4- methylphenyl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 100.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450708&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609144 440826671 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924214 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(C)c2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O5/c1-21-6-4-7-24(18-21)32(2)39-28-9-5-8-25(30(28)40-32)22-12-14-34(15-13-22)20-29-33-26-11-10-23(31(36)37)19-27(26)35(29)16-17-38-3/h4-11,18-19,22H,12-17,20H2,1-3H3,(H,36,37) XJENTJILWDXUND-UHFFFAOYSA-N 450709 US10676465, Example 85::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(3- methylphenyl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 230 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450709&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609085 440826672 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924215 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2Cl)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClN3O5/c1-31(23-7-3-4-8-24(23)32)39-27-9-5-6-22(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-10-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) WAZQKMUDFLJHAI-UHFFFAOYSA-N 450710 US10676465, Example 86::2-({4-[2-(2-chlorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 24.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450710&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609088 440826673 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924216 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2Cl)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClN3O5/c1-31(23-7-3-4-8-24(23)32)39-27-9-5-6-22(29(27)40-31)20-12-14-34(15-13-20)19-28-33-25-11-10-21(30(36)37)18-26(25)35(28)16-17-38-2/h3-11,18,20H,12-17,19H2,1-2H3,(H,36,37) WAZQKMUDFLJHAI-UHFFFAOYSA-N 450710 US10676465, Example 86::2-({4-[2-(2-chlorophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 410 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450710&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609088 440826673 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924217 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2cccc(c2)C#N)nc2ccc(cc12)C(O)=O InChI=1S/C32H32N4O5/c1-32(24-6-3-5-21(17-24)19-33)40-28-8-4-7-25(30(28)41-32)22-11-13-35(14-12-22)20-29-34-26-10-9-23(31(37)38)18-27(26)36(29)15-16-39-2/h3-10,17-18,22H,11-16,20H2,1-2H3,(H,37,38) IBFHYGYBQQBISU-UHFFFAOYSA-N 450711 US10676465, Example 87::2-({4-[2-(3-cyanophenyl)-2-methyl-1,3- benzodioxol-4-yl]piperidin-1-yl}methyl)-1- (2-methoxyethyl)-1H-benzimidazole-6- carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 570 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450711&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609078 440826674 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924218 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2C)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O5/c1-21-7-4-5-9-25(21)32(2)39-28-10-6-8-24(30(28)40-32)22-13-15-34(16-14-22)20-29-33-26-12-11-23(31(36)37)19-27(26)35(29)17-18-38-3/h4-12,19,22H,13-18,20H2,1-3H3,(H,36,37) LZWDXMUVYXRYEK-UHFFFAOYSA-N 450712 US10676465, Example 88::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(2- methylphenyl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 17.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450712&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609052 440826675 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924219 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccc2C)nc2ccc(cc12)C(O)=O InChI=1S/C32H35N3O5/c1-21-7-4-5-9-25(21)32(2)39-28-10-6-8-24(30(28)40-32)22-13-15-34(16-14-22)20-29-33-26-12-11-23(31(36)37)19-27(26)35(29)17-18-38-3/h4-12,19,22H,13-18,20H2,1-3H3,(H,36,37) LZWDXMUVYXRYEK-UHFFFAOYSA-N 450712 US10676465, Example 88::1-(2-methoxyethyl)-2-({4-[2-methyl-2-(2- methylphenyl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, formate salt Glucagon-like peptide 1 receptor Homo sapiens 360 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450712&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609052 440826675 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924220 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccn2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32N4O5/c1-30(26-8-3-4-13-31-26)38-25-7-5-6-22(28(25)39-30)20-11-14-33(15-12-20)19-27-32-23-10-9-21(29(35)36)18-24(23)34(27)16-17-37-2/h3-10,13,18,20H,11-12,14-17,19H2,1-2H3,(H,35,36) ISYFPSDLXJZRQO-UHFFFAOYSA-N 450713 US10676465, Example 89::US10676465, Example 90::1-(2-methoxyethyl)-2-({4-[2-methyl-2- (pyridin-2-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, ENT- X2, trifluoroacetate salt [from C81; footnote 7 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 130 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450713&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609103 440826676 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924221 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccn2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32N4O5/c1-30(26-8-3-4-13-31-26)38-25-7-5-6-22(28(25)39-30)20-11-14-33(15-12-20)19-27-32-23-10-9-21(29(35)36)18-24(23)34(27)16-17-37-2/h3-10,13,18,20H,11-12,14-17,19H2,1-2H3,(H,35,36) ISYFPSDLXJZRQO-UHFFFAOYSA-N 450713 US10676465, Example 89::US10676465, Example 90::1-(2-methoxyethyl)-2-({4-[2-methyl-2- (pyridin-2-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, ENT- X2, trifluoroacetate salt [from C81; footnote 7 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 2900 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450713&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609103 440826676 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924222 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccccn2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32N4O5/c1-30(26-8-3-4-13-31-26)38-25-7-5-6-22(28(25)39-30)20-11-14-33(15-12-20)19-27-32-23-10-9-21(29(35)36)18-24(23)34(27)16-17-37-2/h3-10,13,18,20H,11-12,14-17,19H2,1-2H3,(H,35,36) ISYFPSDLXJZRQO-UHFFFAOYSA-N 450713 US10676465, Example 89::US10676465, Example 90::1-(2-methoxyethyl)-2-({4-[2-methyl-2- (pyridin-2-yl)-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1H- benzimidazole-6-carboxylic acid, ENT- X2, trifluoroacetate salt [from C81; footnote 7 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450713&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609103 440826676 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924223 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cn2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H31ClN4O5/c1-30(26-9-7-21(31)17-32-26)39-25-5-3-4-22(28(25)40-30)19-10-12-34(13-11-19)18-27-33-23-8-6-20(29(36)37)16-24(23)35(27)14-15-38-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,36,37)/p-1 QXJJCZYZPJIMDB-UHFFFAOYSA-M 450715 US10676465, Example 91::ammonium 2-({4-[2-(5-chloropyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 92 Glucagon-like peptide 1 receptor Homo sapiens 14000 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295689 440826677 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924224 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cn2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H31ClN4O5/c1-30(26-9-7-21(31)17-32-26)39-25-5-3-4-22(28(25)40-30)19-10-12-34(13-11-19)18-27-33-23-8-6-20(29(36)37)16-24(23)35(27)14-15-38-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,36,37)/p-1 QXJJCZYZPJIMDB-UHFFFAOYSA-M 450715 US10676465, Example 91::ammonium 2-({4-[2-(5-chloropyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 92 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295689 440826677 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924225 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cn2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H31ClN4O5/c1-30(26-9-7-21(31)17-32-26)39-25-5-3-4-22(28(25)40-30)19-10-12-34(13-11-19)18-27-33-23-8-6-20(29(36)37)16-24(23)35(27)14-15-38-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,36,37)/p-1 QXJJCZYZPJIMDB-UHFFFAOYSA-M 450715 US10676465, Example 91::ammonium 2-({4-[2-(5-chloropyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 92 Glucagon-like peptide 1 receptor Homo sapiens 4.20 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295689 440826677 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924226 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(Cl)cn2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H31ClN4O5/c1-30(26-9-7-21(31)17-32-26)39-25-5-3-4-22(28(25)40-30)19-10-12-34(13-11-19)18-27-33-23-8-6-20(29(36)37)16-24(23)35(27)14-15-38-2/h3-9,16-17,19H,10-15,18H2,1-2H3,(H,36,37)/p-1 QXJJCZYZPJIMDB-UHFFFAOYSA-M 450715 US10676465, Example 91::ammonium 2-({4-[2-(5-chloropyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 92 Glucagon-like peptide 1 receptor Homo sapiens 72.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 153295689 440826677 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924227 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cn2)C#N)nc2ccc(cc12)C([O-])=O InChI=1S/C31H31N5O5/c1-31(27-9-6-20(17-32)18-33-27)40-26-5-3-4-23(29(26)41-31)21-10-12-35(13-11-21)19-28-34-24-8-7-22(30(37)38)16-25(24)36(28)14-15-39-2/h3-9,16,18,21H,10-15,19H2,1-2H3,(H,37,38)/p-1 FDUYFSWCJMPBSD-UHFFFAOYSA-M 450717 US10676465, Example 93::ammonium 2-({4-[2-(5-cyanopyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 94 Glucagon-like peptide 1 receptor Homo sapiens >6500 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818465 440826678 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924228 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cn2)C#N)nc2ccc(cc12)C([O-])=O InChI=1S/C31H31N5O5/c1-31(27-9-6-20(17-32)18-33-27)40-26-5-3-4-23(29(26)41-31)21-10-12-35(13-11-21)19-28-34-24-8-7-22(30(37)38)16-25(24)36(28)14-15-39-2/h3-9,16,18,21H,10-15,19H2,1-2H3,(H,37,38)/p-1 FDUYFSWCJMPBSD-UHFFFAOYSA-M 450717 US10676465, Example 93::ammonium 2-({4-[2-(5-cyanopyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 94 Glucagon-like peptide 1 receptor Homo sapiens >20000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818465 440826678 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924229 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cn2)C#N)nc2ccc(cc12)C([O-])=O InChI=1S/C31H31N5O5/c1-31(27-9-6-20(17-32)18-33-27)40-26-5-3-4-23(29(26)41-31)21-10-12-35(13-11-21)19-28-34-24-8-7-22(30(37)38)16-25(24)36(28)14-15-39-2/h3-9,16,18,21H,10-15,19H2,1-2H3,(H,37,38)/p-1 FDUYFSWCJMPBSD-UHFFFAOYSA-M 450717 US10676465, Example 93::ammonium 2-({4-[2-(5-cyanopyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 94 Glucagon-like peptide 1 receptor Homo sapiens 12.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818465 440826678 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924230 COCCn1c(CN2CCC(CC2)c2cccc3OC(C)(Oc23)c2ccc(cn2)C#N)nc2ccc(cc12)C([O-])=O InChI=1S/C31H31N5O5/c1-31(27-9-6-20(17-32)18-33-27)40-26-5-3-4-23(29(26)41-31)21-10-12-35(13-11-21)19-28-34-24-8-7-22(30(37)38)16-25(24)36(28)14-15-39-2/h3-9,16,18,21H,10-15,19H2,1-2H3,(H,37,38)/p-1 FDUYFSWCJMPBSD-UHFFFAOYSA-M 450717 US10676465, Example 93::ammonium 2-({4-[2-(5-cyanopyridin-2- yl)-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-(2- methoxyethyl)-1H-benzimidazole-6- carboxylate, ENT-X1 [from P8]::US10676465, Example 94 Glucagon-like peptide 1 receptor Homo sapiens 360 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 155818465 440826678 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924231 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cn1 |r| InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38) SVPYZAJTWFQTSM-UHFFFAOYSA-N 450719 US10676465, Example 95**** Glucagon-like peptide 1 receptor Homo sapiens 220 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450719&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609011 440826679 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924232 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4C[C@@H]4CCO4)C(O)=O)CC3)c2O1)c1ccc(Cl)cn1 |r| InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38) SVPYZAJTWFQTSM-UHFFFAOYSA-N 450719 US10676465, Example 95**** Glucagon-like peptide 1 receptor Homo sapiens >13000 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450719&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609011 440826679 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924233 CC1(Oc2c(O1)c(ccc2F)C1CCN(Cc2nc3ccc(cc3n2C[C@@H]2CCO2)C(O)=O)CC1)c1ccc(Cl)cc1F |r| InChI=1S/C32H30ClF2N3O5/c1-32(23-5-3-20(33)15-25(23)35)42-29-22(4-6-24(34)30(29)43-32)18-8-11-37(12-9-18)17-28-36-26-7-2-19(31(39)40)14-27(26)38(28)16-21-10-13-41-21/h2-7,14-15,18,21H,8-13,16-17H2,1H3,(H,39,40) IIDQXCXBRQKHNZ-UHFFFAOYSA-N 450720 US10676465, Example 96::2-({4-[2-(4-chloro-2-fluorophenyl)-7- fluoro-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan- 2-ylmethyl]-1H-benzimidazole-6- carboxylic acid, DIAST-1 [footnote 10 in Table 2]::US10676465, Example 97 Glucagon-like peptide 1 receptor Homo sapiens 1.10 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609160 440826680 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924234 CC1(Oc2c(O1)c(ccc2F)C1CCN(Cc2nc3ccc(cc3n2C[C@@H]2CCO2)C(O)=O)CC1)c1ccc(Cl)cc1F |r| InChI=1S/C32H30ClF2N3O5/c1-32(23-5-3-20(33)15-25(23)35)42-29-22(4-6-24(34)30(29)43-32)18-8-11-37(12-9-18)17-28-36-26-7-2-19(31(39)40)14-27(26)38(28)16-21-10-13-41-21/h2-7,14-15,18,21H,8-13,16-17H2,1H3,(H,39,40) IIDQXCXBRQKHNZ-UHFFFAOYSA-N 450720 US10676465, Example 96::2-({4-[2-(4-chloro-2-fluorophenyl)-7- fluoro-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan- 2-ylmethyl]-1H-benzimidazole-6- carboxylic acid, DIAST-1 [footnote 10 in Table 2]::US10676465, Example 97 Glucagon-like peptide 1 receptor Homo sapiens 11.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609160 440826680 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924235 CC1(Oc2c(O1)c(ccc2F)C1CCN(Cc2nc3ccc(cc3n2C[C@@H]2CCO2)C(O)=O)CC1)c1ccc(Cl)cc1F |r| InChI=1S/C32H30ClF2N3O5/c1-32(23-5-3-20(33)15-25(23)35)42-29-22(4-6-24(34)30(29)43-32)18-8-11-37(12-9-18)17-28-36-26-7-2-19(31(39)40)14-27(26)38(28)16-21-10-13-41-21/h2-7,14-15,18,21H,8-13,16-17H2,1H3,(H,39,40) IIDQXCXBRQKHNZ-UHFFFAOYSA-N 450720 US10676465, Example 96::2-({4-[2-(4-chloro-2-fluorophenyl)-7- fluoro-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan- 2-ylmethyl]-1H-benzimidazole-6- carboxylic acid, DIAST-1 [footnote 10 in Table 2]::US10676465, Example 97 Glucagon-like peptide 1 receptor Homo sapiens 14.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609160 440826680 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924236 CC1(Oc2c(O1)c(ccc2F)C1CCN(Cc2nc3ccc(cc3n2C[C@@H]2CCO2)C(O)=O)CC1)c1ccc(Cl)cc1F |r| InChI=1S/C32H30ClF2N3O5/c1-32(23-5-3-20(33)15-25(23)35)42-29-22(4-6-24(34)30(29)43-32)18-8-11-37(12-9-18)17-28-36-26-7-2-19(31(39)40)14-27(26)38(28)16-21-10-13-41-21/h2-7,14-15,18,21H,8-13,16-17H2,1H3,(H,39,40) IIDQXCXBRQKHNZ-UHFFFAOYSA-N 450720 US10676465, Example 96::2-({4-[2-(4-chloro-2-fluorophenyl)-7- fluoro-2-methyl-1,3-benzodioxol-4- yl]piperidin-1-yl}methyl)-1-[(2S)-oxetan- 2-ylmethyl]-1H-benzimidazole-6- carboxylic acid, DIAST-1 [footnote 10 in Table 2]::US10676465, Example 97 Glucagon-like peptide 1 receptor Homo sapiens 140 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609160 440826680 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924237 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C([O-])=O)CC3)c2O1)c1ccc(cc1F)C#N InChI=1S/C33H28FN5O5/c1-33(24-7-5-20(17-35)15-25(24)34)43-28-4-2-3-23(31(28)44-33)21-9-12-38(13-10-21)18-29-37-26-8-6-22(32(40)41)16-27(26)39(29)19-30-36-11-14-42-30/h2-8,11,14-16,21H,9-10,12-13,18-19H2,1H3,(H,40,41)/p-1 CVWLLOGSBBTZOM-UHFFFAOYSA-M 450722 US10676465, Example 98::US10676465, Example 99::ammonium 2-({4-[2-(4-cyano-2- fluorophenyl)-2-methyl-1,3-benzodioxol- 4-yl]piperidin-1-yl}methyl)-1-(1,3-oxazol- 2-ylmethyl)-1H-benzimidazole-6- carboxylate, ENT-X2 [from C83; footnote 12 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 50.0 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450722&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 147299940 440826681 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924238 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C([O-])=O)CC3)c2O1)c1ccc(cc1F)C#N InChI=1S/C33H28FN5O5/c1-33(24-7-5-20(17-35)15-25(24)34)43-28-4-2-3-23(31(28)44-33)21-9-12-38(13-10-21)18-29-37-26-8-6-22(32(40)41)16-27(26)39(29)19-30-36-11-14-42-30/h2-8,11,14-16,21H,9-10,12-13,18-19H2,1H3,(H,40,41)/p-1 CVWLLOGSBBTZOM-UHFFFAOYSA-M 450722 US10676465, Example 98::US10676465, Example 99::ammonium 2-({4-[2-(4-cyano-2- fluorophenyl)-2-methyl-1,3-benzodioxol- 4-yl]piperidin-1-yl}methyl)-1-(1,3-oxazol- 2-ylmethyl)-1H-benzimidazole-6- carboxylate, ENT-X2 [from C83; footnote 12 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 440 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450722&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 147299940 440826681 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924239 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C([O-])=O)CC3)c2O1)c1ccc(cc1F)C#N InChI=1S/C33H28FN5O5/c1-33(24-7-5-20(17-35)15-25(24)34)43-28-4-2-3-23(31(28)44-33)21-9-12-38(13-10-21)18-29-37-26-8-6-22(32(40)41)16-27(26)39(29)19-30-36-11-14-42-30/h2-8,11,14-16,21H,9-10,12-13,18-19H2,1H3,(H,40,41)/p-1 CVWLLOGSBBTZOM-UHFFFAOYSA-M 450722 US10676465, Example 98::US10676465, Example 99::ammonium 2-({4-[2-(4-cyano-2- fluorophenyl)-2-methyl-1,3-benzodioxol- 4-yl]piperidin-1-yl}methyl)-1-(1,3-oxazol- 2-ylmethyl)-1H-benzimidazole-6- carboxylate, ENT-X2 [from C83; footnote 12 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 2.80 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450722&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 147299940 440826681 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924240 CC1(Oc2cccc(C3CCN(Cc4nc5ccc(cc5n4Cc4ncco4)C([O-])=O)CC3)c2O1)c1ccc(cc1F)C#N InChI=1S/C33H28FN5O5/c1-33(24-7-5-20(17-35)15-25(24)34)43-28-4-2-3-23(31(28)44-33)21-9-12-38(13-10-21)18-29-37-26-8-6-22(32(40)41)16-27(26)39(29)19-30-36-11-14-42-30/h2-8,11,14-16,21H,9-10,12-13,18-19H2,1H3,(H,40,41)/p-1 CVWLLOGSBBTZOM-UHFFFAOYSA-M 450722 US10676465, Example 98::US10676465, Example 99::ammonium 2-({4-[2-(4-cyano-2- fluorophenyl)-2-methyl-1,3-benzodioxol- 4-yl]piperidin-1-yl}methyl)-1-(1,3-oxazol- 2-ylmethyl)-1H-benzimidazole-6- carboxylate, ENT-X2 [from C83; footnote 12 in Table 2] Glucagon-like peptide 1 receptor Homo sapiens 5.40 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450722&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 147299940 440826681 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924241 C[C@@]1(Oc2cccc(C3CCN(Cc4nc5ccc(C(O)=O)c(F)c5n4C[C@@H]4CCO4)CC3)c2O1)c1ccc(Cl)cc1F |r| InChI=1S/C32H30ClF2N3O5/c1-32(23-7-5-19(33)15-24(23)34)42-26-4-2-3-21(30(26)43-32)18-9-12-37(13-10-18)17-27-36-25-8-6-22(31(39)40)28(35)29(25)38(27)16-20-11-14-41-20/h2-8,15,18,20H,9-14,16-17H2,1H3,(H,39,40) WHJPBEHUCSCVDL-UHFFFAOYSA-N 450724 US10676465, Example 100::2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)-2- methyl-1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-7-fluoro-1[(2S)-oxetan-2- ylmethyl]-1H-benzimidazole-6-carboxylic acid, hemicitrate salt [from P3] Glucagon-like peptide 1 receptor Homo sapiens 7.60 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450724&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146608983 440826682 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924242 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc4O[C@@H](Oc34)c3ccc(Cl)cc3F)n(C[C@@H]3CCO3)c2c1F |r| InChI=1S/C31H28ClF2N3O5/c32-18-4-5-21(23(33)14-18)31-41-25-3-1-2-20(29(25)42-31)17-8-11-36(12-9-17)16-26-35-24-7-6-22(30(38)39)27(34)28(24)37(26)15-19-10-13-40-19/h1-7,14,17,19,31H,8-13,15-16H2,(H,38,39) PWQZKTQMSAADQD-UHFFFAOYSA-N 450725 US10676465, Example 101::2-({4-[(2S)-2-(4-chloro-2-fluorophenyl)- 1,3-benzodioxol-4-yl]piperidin-1- yl}methyl)-7-fluoro-1-[(2S)-oxetan-2- ylmethyl]-1H-benzimidazole-6-carboxylic acid, hemicitrate salt [from C48] Glucagon-like peptide 1 receptor Homo sapiens 19.0 US Patent 10.7270/Q2GF0XJS aid1804574 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450725&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609034 440826683 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 924243 COCCn1c(CN2CCC(CC2)c2cccc3OC(CO)(Oc23)c2ccccc2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33N3O6/c1-38-17-16-34-26-18-22(30(36)37)10-11-25(26)32-28(34)19-33-14-12-21(13-15-33)24-8-5-9-27-29(24)40-31(20-35,39-27)23-6-3-2-4-7-23/h2-11,18,21,35H,12-17,19-20H2,1H3,(H,36,37) LQIWTJOJHHVIRP-UHFFFAOYSA-N 450726 US10676465, Example 102 Glucagon-like peptide 1 receptor Homo sapiens 600 US Patent 10.7270/Q2GF0XJS aid1804573 US10676465 Aspnes, GE; Bagley, SW; Curto, JM; Edmonds, DJ; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Lian, Y; Limberakis, C; Londregan, AT; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 6/9/2020 3/11/2021 Pfizer http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=450726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=450726&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 146609057 440826684 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 7FIM,9X22,9J1P,9IVM,9IVG,8YWF,8YW3,8WG7,8JIR,8JIP,7VBI,7VBH,7EVM,7E14,7DUR,7DUQ,8JIS,6GB1,5E94,3IOL,4ZGM,3C5T,3C59,5OTX,5OTW,5OTV,5OTU,5OTT Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669